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 Summary 
 
 
The endothelin B receptor belongs to the rhodopsin-like G-protein coupled receptors family. 
It plays an important role in vasodilatation and is found in the membranes of the endothelial 
cells enveloping blood vessels. 
During the course of this work, the production of recombinant human ETB receptor in yeast, 
insect and mammalian cells was evaluated. 
A number of different receptor constructs for production in the yeast P. pastoris was 
prepared. Various affinity tags were appended to the receptor N-and C-termini to enable 
receptor detection and purification. The clone pPIC9KFlagHisETBBio, with an expression 
level of 60 pmol/mg, yielded the highest amount of active receptor (1.2 mg of receptor per 
liter of shaking culture). The expression level of the same clone in fermentor culture was 17 
pmol/mg, and from a 10L fermentor it was possible to obtain 3 kg of cells that contained 20-
39 mg of the receptor. 
For receptor production in insect cells, Sf9 (S. frugiperda) suspension cells were infected with 
the recombinant baculovirus pVlMelFlagHisETBBio. The peak of receptor production was 
reached at 66 h post infection, and radioligand binding assays on insect cell membranes 
showed 30 pmoL of active receptor /mg of membrane protein. Subsequently, the efficiency of 
different detergents in solubilizing the active receptor was evaluated. N-dodecyl-β-D-
maltoside (LM), lauryl-sucrose and digitonine/cholate performed best, and LM was chosen 
for further work. 
The ETB receptor was produced in mammalian cells using the Semliki Forest Virus 
expression system. Radioligand binding assays on membranes from CHO cells infected with 
the recombinant virus pSFV3CAPETBHis showed 7 pmol of active receptor /mg of membrane 
protein. Since the receptor yield from mammalian cells was much lower than in yeast and 
insect cells, this system was not used for further large-scale receptor production. 
After production in yeast and insect cells, the ETB receptor was saturated with its ligand, 
endothelin-1, in order to stabilize its native form. The receptor was subsequently solubilized 
with n-dodecyl-β-D-maltoside and subjected to purification on various affinity matrices. Two-
step affinity purification via Ni
2+-NTA and monomeric avidin proved the most efficient way 
to purify milligram amounts of the receptor. The purity of the receptor preparation after this 
procedure was over 95%, as judged from silver stained gels. However, the tendency of the 
ETB receptor produced in yeast to form aggregates was a constant problem. Attempts were 
  1made to stabilize the active, monomeric form of the receptor by testing a variety of different 
buffer conditions, but further efforts in this direction will be necessary in order to solve the 
aggregation problem.  
In contrast to preparations from yeast, the purification of the ETB receptor produced in insect 
cells yielded homogeneous receptor preparations, as shown by gel filtration analysis. 
This work has demonstrated that the amounts of receptor expressed in yeast and insect cells 
and the final yield of receptor, isolated by purification, represent a good basis for beginning 
3D and continuing 2D crystallization trials. 
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1 Introduction 
 
1.1  Membrane receptors 
 
The cell is the smallest functional unit of the organism, a closed microsystem capable of 
maintaining its own homeostasis. It can also function as a part of a larger system – the 
multicellular organism - and must do so perfectly in accord with the neighbouring cells. A 
crucial factor making that possible is the communication between the cell and its 
surroundings. Cells in higher animals communicate by means of hundreds of kinds of 
signalling molecules, ranging from small peptides and proteins to amino acids, nucleotides, 
steroids, fatty acid derivatives, even dissolved gasses like nitric oxide. Some of those 
molecules, being small and hydrophobic, enter the target cell directly by diffusing through the 
lipid bilayer of the plasma membrane. They then activate intracellular receptor proteins, 
which directly regulate the transcription of specific genes. But the majority of extracellular 
signalling molecules are hydrophilic and therefore not able to enter the cell by diffusion. 
Instead, these molecules initiate the signalling cascade via binding to and activating plasma 
membrane receptors. Plasma membrane receptors are integral membrane proteins capable of 
binding a messenger molecule on their extracellular side and transducing the signal to the cell 
interior. 
There are three distinctive types of membrane receptors, classified according to their structure 
and the type of transducing mechanism:  
•  transmitter-gated ion channels 
•  enzyme-linked receptors 
•  G protein-coupled receptors (GPCRs) 
Transmitter-gated ion channels are ionotropic receptors involved in rapid synaptic signalling 
between electrically excitable cells. This type of signalling is mediated by certain 
neurotransmitters which transiently open or close the ion channel formed by the protein they 
bind to, thus briefly changing the permeability of the plasma membrane. Nicotinic 
acetylcholine receptors, ATP P2X receptors and NMDA receptors are some examples of this 
receptor type. 
Enzyme-linked receptors represent the class of single transmembrane helix (TMH) receptors, 
which upon activation function either directly as enzymes or activate the enzyme to which 
they bind. Their ligand-binding site is situated on the extracellular side of the plasma 
membrane, and their catalytic or enzyme-binding site, inside the cell. The majority are protein 
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kinases,  i.e. when activated, they cause the phosphorylation of target proteins. Receptors 
belonging to this class mostly form dimers in their active state. Characteristic examples are 
some cytokine and the growth factor hormone receptors.  
GPCRs are a highly diverse group of 7TMH receptors, accounting for 80% of the total 
membrane receptor gene population. They indirectly, via intracellular G-proteins, regulate the 
activity of a specific set of target proteins (ion channels and enzymes). Activated ion channels 
change membrane permeability for ions. If the activated protein is an enzyme, it changes the 
concentration of one or more intracellular mediators, continuing the signalling cascade and 
enabling the cell to respond to the external signal. 
 
1.2       Portrait of a GPCR  
 
The largest and pharmacologically most interesting group of membrane receptors is the G 
protein-coupled receptor (GPCR) superfamily. Genes encoding GPCRs comprise 1-5% of the 
vertebrate genome (~1% of the human genome). As to their pharmacological importance – 
GPCRs have emerged as the most prominent class of drug targets for the pharmaceutical 
industry. It is estimated that around 50% of currently marketed drugs represent modulators of 
GPCR function (Drews, 2000).  
The GPCR superfamily members share two common characteristics:  
•  a structural pattern consisting of seven membrane-spanning helices  
•  the ability to couple to the intracellular G proteins upon activation (hence the name)  
GPCR superfamily comprises five classes of receptors, classified according to their structural 
homology (Kolakowski, 1994):  
 
 
Receptor Family      Code   Group  Members   
     Prototype   
 
               
     Olfactory and adenosine receptors 
     B i o g e n i c   a m i n e   r e c e p t o r s  
β2-adrenergic       A   Peptide  receptors 
receptor     Vertebrate  photopigments 
     I n v e r t e b r a t e   p h o t o p i g m e n t s  
     Paracrine/autocrine  receptors   
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Receptor Family      Code   Group  Members   
     Prototype   
 
 
Calcitonin-like receptors  
Calcitonin        B   PTH/PTHrP  receptors 
receptor     Secretin-like  receptors 
 
Metabotropic     Other  metabotropic    
glutamate         C   glutamate  receptors 
receptor 
 
Fungal  pheromone    STE2 
receptors        D   STE3 
 
D. discoideum      
CAMP receptors      E    Other cAMP receptors 
 
 
TABLE 1  The GPCR receptor superfamily (modified after Kolakowski, 1994) 
 
 
Because of their overall importance, research efforts to elucidate GPCR three-dimensional 
(3D) structures have a long history. The structural analysis of bacteriorhodopsin 2D crystals 
by electron microscopy and 3D crystals by X-ray crystallography yielded the first reliable 
insights into the 3D structure of a protein with 7 transmembrane helices (Henderson and 
Unwin, 1975; Henderson and Baldwin, 1990). Until relatively recently, when the 3D structure 
of the phototransducer rhodopsin was solved (Palczewski et al., 2000), GPCR structural 
models were based on the structure of bacteriorhodopsin (which is not a GPCR itself, but 
shares the seven transmembrane helical motif) and the 2D structure of bovine rhodopsin 
(Schertler  et al., 1993). Recently published 3D structure of bovine rhodopsin based on 
electron cryo-microscopy (Krebs et al., 2003) provides complementary information to the 
rhodopsin atomic structure by Palczewski et al. and yet more data for reliable GPCR structure 
modelling. 
Rhodopsin is unique among GPCRs for having its ligand, 11-cis-retinal, covalently attached 
and activated by photons. The X-ray structure of bovine rhodopsin by Palczewski et al. was 
the first, and remains the only, high-resolution structure of any GPCR to date. Owing to the 
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relatively high resolution of 2.8 Å, it represents a valid basis for structure prediction of the 
other GPCR superfamily members and for elucidating the mechanism of receptor function. 
 
     
              
1.2.1  GPCR mechanism of action 
From a functional point of view, all the GPCR superfamily members represent (function as) 
transmembrane transducer systems, transferring an extracellular signal across the cell 
membrane and enabling the cell to respond to a broad range of stimuli. Upon ligand binding 
on the extracellular side, the receptor undergoes a conformational change. 
 
 
 
Fig 1.1     3D structure of 
rhodopsin at 2.8 Å resolution.  
(From Palczewski et al., 2000) 
Fig 1.2 
G-protein cycle 
(From 
Offermans, 2003) 
 
RGS protein =
regulator of G-
protein signalling,
which accelerates Gα
GTPase activity.
CTX = cholera
toxin, which blocks
GTPase activity of
Gα subunit. Further
explanations in the
text. 
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If the ligand is an agonist, this conformational change is followed by coupling with 
heterotrimeric GDP-bound G-protein on the cytoplasmic side of the receptor, causing the 
dissociation of the G-protein complex into α and βγ subunits. These subunits further activate 
networks of various effectors (Fig 1.2).  
It should be noted that certain GPCRs exhibit constitutive activity under physiological 
conditions, i.e. can activate G proteins in the absence of ligand. 
 
G-proteins are trimeric GTP-binding proteins, consisting of an α, β and γ subunit. The α 
subunit is a GTPase and functions as a molecular switch that can flip between two states: 
active, when GTP is bound, and inactive, when GDP is bound. Activated receptors switch on 
G-proteins by associating with them and causing them to eject the GDP bound on the Gα, 
replace it with GTP and dissociate to Gα and βγ subunits. The switch is turned off when the 
Gα subunit hydrolyses bound GTP, converting it back to GDP, and reunites with the βγ 
subunit, reconstituting an inactive G-protein trimer (Fig 1.2). Before that occurs, the active 
subunits have had enough time to diffuse away from the receptor and deliver the message to 
the downstream targets. 
 
 
  
   
AC (-) 
K
+ channel (+) 
VSCC (-) 
Na
2+channel (-)
Cl
- channel (-)
 
AC 
    ACII and IV (+) 
    ACI (-) 
PLCβ (+) 
GIRK (+) 
PI3K (+) 
Small G-protein (+) 
VSCC (-) 
Small G-
protein (+)
NRTK (+)
PLCβ (+)  AC (+) 
VSCC (+) 
Na
2* channel (+) 
Cl
- channel (+) 
γ 
β  α12/13  αq/11  αi/o  αs 
 
 
 
 
 
 
 
 
Fig 1.3    Effector molecules regulated by G protein family. 
AC = adenylyl-cyclase, VSCC = voltage-sensitive calcium channel, PLC = phospholipase,    
NRTK = non-receptor tyrosine kinase, GIRK = inward rectifier G-protein gated potassium 
channels, PI3K = phospatidylinositol-3-kinase. (+) indicates activation, (-) indicates 
inhibition 
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In humans, there are 21 different Gα subunits, 5 β subunits and 11 different γ subunits (rev. in 
Hepler and Gilman, 1992; Hamm and Gilchrist, 1996). Depending on the molecular nature of 
the α subunit, G proteins are generally classified into four different families: Gαs (olf) (Itoh, 
1986; Harris, 1988), Gαi (Itoh, 1986), Gαq (Exton, 1996) and Gα12(13) (Strathmann and Simon, 
1990). They activate different sets of effectors, as shown in Fig 1.3. “Stimulatory” Gα 
proteins (i.e. Gs) activate the enzyme adenylate cyclase (AC), resulting in an increased level 
of cyclic AMP (cAMP) in the cell, and “inhibitory” Gα  proteins (i.e. Gi) act as AC inhibitors 
and lower intracellular cAMP levels. Another class of Gα proteins, Gq , activates the enzyme 
phospholipase C-β, which triggers the events leading to an increase in cytosolic Ca
2+ 
concentration. Alteration of cAMP and Ca
2+ intracellular concentrations leads to activation of 
different sets of kinases, which further phosphorylate specific target proteins, altering their 
activity and enabling the cell to respond to a myriad of external stimuli. 
Most GPCRs are able to couple to more than one kind of G protein, which provides diversity 
of signalling even with stimulation of only one particular receptor type. 
In addition to G-proteins, GPCRs interact with a number of different proteins that either 
couple GPCRs to G-protein independent signal transduction pathways or alter G protein 
specificity and agonist selectivity. These proteins include arrestins, G protein-coupled 
receptor kinases (GRKs), calmodulin, the Homer protein, SH3 domain-containing molecules 
and small G-proteins (reviewed in Ferguson, 2001). 
It should also be noted that, in contrast to the large number of different GPCRs, the number of 
identified effectors they indirectly regulate is considerably smaller. This convergence leads to 
cross-regulation in signalling pathways, yielding yet more diverse physiological responses. 
 
Termination of GPCR signalling initiated by ligand binding is called receptor desensitization, 
and it represents an important physiological mechanism that protects the cell from both acute 
and chronic receptor overstimulation. In the course of the desensitization process, uncoupling 
of the GPCR from G-proteins occurs as a consequence of receptor phosphorylation by 
intracellular kinases. These G-protein receptor kinases (GRKs) selectively phosphorylate 
agonist-activated receptors, promoting the binding of β-arrestins to the receptor, which 
sterically uncouple the receptor from the G protein and target the receptor for endocytosis and 
subsequent degradation or recycling (Lohse, 1993; Ferguson et al., 1996). 
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1.2.2  Compartmentalization & dimerization of GPCRs 
 
The classical view of the GPCR signalling process is based on random collisions between the 
proteins that freely diffuse in the plasma membrane, where the specificity of interaction is 
entirely dependent on the 3D structure of the respective molecules and their matching 
recognition surfaces. However, recent evidence suggests that the whole system is less mobile 
than previously predicted, and is organized in distinct microdomains in the plasma membrane, 
namely calveolae and lipid rafts (Neubig et al., 1994; Ostrom et al., 2000). It has been 
suggested that caveolae localization represents a mechanism for amplifying extracellular 
signals by increasing the proximity, and therefore coupling, of receptors and effectors (Lisanti 
et al., 1994). 
 
Another newly emerging functional aspect of GPCR signalling is dimerization. Although this 
concept is well known and represents a necessary prerequisite for the activation of enzyme-
linked receptors, the conventional assumption in the case of the GPCR superfamily was that 
monomeric receptors act allosterically with a single heterotrimeric G-protein. But recent 
evidence for the homodimerization of opioid receptors (Jordan and Devi, 1999), β2 
adrenergic receptors (Hebert et al., 1998), vasopressin receptors (Zhu and Wess, 1998) and 
bradykinin receptors (AbdAlla et al., 2000) suggests that the classical model of GPCR modes 
of action requires alteration. Additionally, there is ample evidence of heterodimerization of 
GPCRs, both between different subtypes of the same receptor, as in the case of GABA 
receptors (Marshal et al., 1999; White et al., 1998), opioid receptors (Gomes et al., 2002) and 
muscarinic receptors (Zeng and Wess, 2000), and also between different receptor types, as in 
the case of dopamine and somatostatin receptors (Rocheville et al., 2000) and adrenergic and 
opioid receptors (Jordan et al., 2001), suggesting that this process may be important for 
GPCR biogenesis, activation and function (reviewed in e.g. Rios et al., 2001; Bouvier, 2002). 
In the case of receptor heterodimerization, the generation of sites with novel ligand-binding 
properties has been reported (Maggio et al., 1999; Jordan and Devi, 1999). 
 
1.3  Endothelin signalling system 
 
In 1988, Yanagisawa et al. discovered an active substance in the endothelial cell homogenate, 
which showed a strong vasoconstrictive effect. The active substance was a 21 amino acid long 
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peptide, which they named “endothelin”. Yanagisawa et al. had actually isolated the most 
abundant peptide isoform of endothelin in humans, ET-1. Since then, two other isoforms of 
the peptide, termed ET-2 and ET-3, have been found in humans, each coded by a different 
gene (Inoue et al, 1989).  Each isoform is first expressed as a precursor protein, the 200 amino 
acid prepro-endothelin, which is then cleaved by a peptidase to yield “big”, 39 amino acid 
long ET (Fig 1.4). “Big” ET is converted to the mature peptide by the metalloproteinase 
endothelin-converting enzyme (ECE). Mature peptides are 21 amino acids long, have two 
intrachain disulfide bonds (Cys1-Cys15 and Cys3-Cys11) and a conserved C-terminal 
sequence needed for activity (Inoue et al., 1989). The 3D crystal structure of endothelin ET-1 
at 2.18 A is available (Janes et al., 1994).  
 
 
ECE-1   Prepro-ET-1 mRNA  Prepro-ET-1  Pro-ET-1  ET-1 
 
   Fig 1.4      The synthesis of ET-1 
 
Endothelins are found in various mammalian tissues, with different distribution patterns.  By 
far the most abundantly expressed is ET-1. This isoform is the only one found in vascular 
endothelial cells, but it is also found in non-vascular tissues, like brain, kidney, adrenal gland, 
intestine and myocardium (Sakurai et al., 1991). ET-2 and ET-3 are found in different non-
vascular tissues, with ET-3 being relatively abundant in neural tissues (Bloch et al., 1989). 
The biological activity of endothelins is regulated by a complex process of synthesis and 
breakdown. Mature endothelin is packed and transported in secretory vesicles through a 
cyclic AMP-independent pathway. ET-1 is also stored in Weibel-Palade bodies (with other 
vasoactive compounds) from which it is released on the cell surface after appropriate stimuli 
(i.e. fluid shear stress, interleukin 1, angiotensin II, TGF β - Russel et al., 1998).  
ET-1 is secreted from vascular endothelial cells to the immediate surrounding, provoking 
directly the contraction of vascular smooth muscles, so its plasma concentration is usually 
very low – in the low picomolar range.  
Endothelin is mainly metabolized by a neutral endopeptidase, a membrane bound enzyme in 
the proximal tubules of kidney (Abassi et al., 1993), which is widely involved in the 
degradation of peptide hormones. Endothelin could be also cleared by binding to the ETB 
receptor, which then internalizes and is targeted to lysozomes for degradation.  
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    ET-1    Cys  Ser  Cys  Ser  Ser  Leu  Met  Asp  Lys  Glu  Cys  Val  Tyr  Phe  Cys  His  Leu  Asp  Ile  Ile  Trp 
    ET-2    Cys  Ser  Cys  Ser  Ser  Trp  Leu   Asp  Lys  Glu  Cys  Val  Tyr  Phe  Cys  His  Leu  Asp  Ile  Ile  Trp 
    ET-3    Cys  Thr  Cys  Phe Thr Tyr  Lys   Asp   Lys  Glu  Cys  Val  Tyr  Tyr  Cys  His  Leu  Asp  Ile  Ile  Trp   
 
 SRT-6a1 Cys  Ser  Cys  Lys Asp Met  Thr  Asp  Lys  Glu  Cys  Leu  Asn  Phe Cys His  Gln  Asp  Val  Ile  Trp  
 SRT-6b  Cys  Ser  Cys  Lys  Asp Met  Thr  Asp  Lys  Glu  Cys  Leu   Tyr  Phe Cys His  Gln  Asp  Val  Ile  Trp  
 
Fig 1.5      Endothelins and sarafotoxins - amino acid sequence comparison 
 
Endothelins show a striking structural similarity (Fig 1.5) with the group of extremely 
poisonous cardiotoxic snake venom peptides, named sarafotoxins (Kloog et al., 1988). 
Sarafotoxins are highly lethal peptides: in mice, the LD50 is 15µg/kg body weight and the 
LD50 for endothelin is the same (Bdolah et al., 1989), which is quite surprising for a peptide 
naturally occurring in the plasma of healthy humans. It seems that efficient control 
mechanisms exist in the human organism, which prevent the build-up of ET concentration 
above a certain threshold. However, elevated levels of ET-immunoreactivity have been 
detected in several disease states (e.g. hypertension, renal failure, myocardial arrhythmias and 
ischemia, asthma, arteriosclerosis) (Sokolovsky, 1995 and references therein). 
Despite their potent and extremely long-lasting vasoconstrictor activities, endothelins can 
provoke vasodilatation under physiological conditions as well. Their most prominent role is in 
regulating blood pressure. They also elicit a wide spectrum of both vascular and non-vascular 
actions in a variety of tissues, including airways (bronchoconstriction), kidneys (various 
glomerular and tubular effects), myocardium (positive chronotropic actions), and central and 
peripheral nervous system (modulation of neurotransmission and release of neuroendocrine 
hormones) (Yanagisawa and Masaki, 1989). Such a diversity of action of endothelins can be 
explained in terms of the existence of more than one receptor subtype they bind to, which 
then activate different sets of effectors. 
 
1.3.1 Endothelin  receptors 
 
Two subtypes of endothelin receptors, ETA and ETB, have been identified in humans (Arai et 
al., 1990; Nakamuta et al., 1991). A putative third type of endothelin receptor, ETC, has been 
identified in Xenopus laevis (Kumar et al., 1994), but no known homologue has been found in 
the human genome.  
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Endothelin receptors are members of the class A (rhodopsin-like) family of GPCRs, and share 
common structural features. They have 63% homology in primary structure, and differ in 
affinity towards the peptide isoforms of endothelin. ETA has a higher binding affinity for ET-
1 and ET-2 than for ET-3 (Arai et al., 1990), whereas the ETB  receptor binds the three 
isoforms with comparable affinity, i.e. is non-selective. The complex formed upon binding of 
endothelin to the receptor is known to be extremely stable and release or exchange of the 
ligand from the receptor is very slow under physiological conditions (Martin et al, 1989, 
Clozel et al, 1989). Furthermore, the ET-1 complex with ETB survives in the presence of 1% 
SDS, at reduced temperature (Fischli et al., 1989). 
 
TABLE 2   Different tissue distribution of ET receptors and pharmacological effects of 
endotheline (Modified after Remuzzi et al., 2002) 
 
 
Tissue/organ     Pharmacological effect of ET    ET receptor 
Vasculature    -transient  vasodilation    ETB 
    -sustained  vasoconstriction     ETA 
 
Heart     -increased  coronary  vascular  resistance   ETA 
    -decreased  cardiac  output     ETA 
 
Kidney     -renal  vasoconstriction     ETA 
    -increased  glomerular  afferent  and  efferent   ETA 
     a r t e r i o l a r   t o n e      
    -natriuresis,  diuresis      ETA&ETB 
        -increased proton secretion in proximal tubule  ETB 
      
Lung     -pulmonary-artery  constriction    ETA 
    -contraction/proliferation of airway smooth   ETB 
     m u s c l e  
    -mucous  gland  hypersecretion    ETA&ETB 
-potentiation of cholinergic neuronal function  ETB 
  
 
Brain     -constriction  of  cerebral  arteries    ETA 
    -activation  of  Na/K/Cl  transporter  function   ETA&ETB 
     on  brain  capillary  endothelial  cells 
    -inhibition  of  generation of second messengers  ETB 
     by  neurotransmitter  catecholamines 
      
Parathyroid gland    -increased proliferation of parathyroid cells   ETA&ETB 
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Both subtypes of endothelin receptor possess unusually long N-terminal domains compared to 
other rhodopsin-like GPCRs. It has been shown that the initial N-terminal 26 residues 
function as an internal signal sequence necessary for membrane insertion, which is cleaved 
during translocation (Saito et al., 1991). ETA receptors reside in vascular smooth muscle cells 
and generally mediate vasoconstriction and cell proliferation (Davenport et al. 2002), whereas 
ETB receptors are found on endothelial cells and are mainly vasodilatory, inducing NO release 
upon stimulation (Verhaar et al., 1998). ETB receptors are also clearance receptors for ET 
from circulation (Fukuroda et al., 1994).  
The distribution of ET receptors in target organs for the pharmacological effects of endothelin 
is summarized in Table 2.  
 
1.3.2 ETA and ETB mode of action 
 
ET receptor subtypes exhibit different modes of action as a result of the activation of separate 
effector networks. As depicted in Fig 1.6, the ETA and ETB receptors both activate the Gq 
pathway, which stimulates phosphatidylinositol phosphate (PIP) turnover and increases 
intracellular Ca
2+ concentrations. The receptors differ though in their effects on the adenylate-
cyclase-dependent pathway: ETA activates Gs to increase cAMP formation, whereas ETB 
attenuates forskolin-stimulated cAMP synthesis via Gi (Aramori and Nakanishi, 1992). Both 
ETA and ETB stimulate arachnidonic acid release from PIP, probably via phospholipase A2 
activation, and potently enhance the mitogenic activity of many cell types (Janakidevi et al., 
1992; Takuwa et al., 1989). Whether these effects are indirectly produced by the increase in 
Ca
2+ concentration and/or by modulation of cAMP formation, or whether they are caused by 
direct activation of effector enzymes is presently unknown (Cramer et al., 2001). 
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Fig 1.6   ETA and ETB mode of action. IP3 = inositol triphosphate, PLC = phospholipase C, 
DAG = diacylglycerol, PKC = protein kinase C, MAPK = mitogen-activated protein 
kinase, RTK = receptor tyrosine kinase, PLA2 = phospholipase A2, PI3K = 
phosphatidylinositol 3-kinase, PLD = phospholipase D (after Remuzzi et al., 2002) 
 
 
1.3.3 The  ETB receptor 
 
The protein chain of the human ETB receptor consists of 442 amino acids (Sakamoto et al., 
1991). It has a rather long extracellular N-terminal domain (Fig 1.7) where the first 26 
residues represent the cleavable signal sequence (14 of which are hydrophobic). On the 
extracellular side, one putative N-glycosylation site is found, Asn59. The receptor has seven 
transmembrane segments, 21-27 amino acids long, three extracellular- and three intracellular 
loops, and an intracellular C-terminus. The C-terminus has several phosphorylation sites, 
where either G-protein receptor kinase (GRK) or protein kinase C (PKC) catalyses receptor 
phosphorylation. Cys402, Cys403 and Cys405 on the C-terminus are potential palmitoylation 
sites. Between extracellular Cys174 and Cys255 a disulfide bond exists, which is a common 
characteristic of rhodopsin-like GPCRs (Dohlman et al., 1990).  
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Fig 1.7        Schematic representation of the ETB receptor 
 
 
1.3.3.1     Posttranslational modifications of the ETB receptor 
 
1)  Glycosylation – the human ETB receptor contains a consensus glycosylation site at 
Asn59, and there is evidence that the receptor is glycosylated when expressed in insect 
and mammalian cells (Doi et al., 1997). Substitution of Asn59 with alanine causes no 
change in receptor expression and ligand binding capacity in Sf9 cells (Doi et al., 
1997).  
2)  Phosphorylation – the ETB receptor is rapidly phosphorylated on the C-terminal serine 
and threonine residues upon agonist stimulation (Cramer et al., 1997). This process is 
catalyzed by GRK (Bremnes et al., 2000). Phosphorylated receptor binds β-arrestin 
and is thereby internalized and targeted to lysosymes where it is degraded.   
3) Palmitoylation – covalent attachment of palmitic acid to the conserved cysteine 
residues in the C-terminal region of many GPCRs is a modification, which provides a 
hydrophobic anchor that is inserted to the membrane, thereby creating an extra loop in 
the cytosolic receptor portion. The ETB receptor possesses three potential 
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palmitoylation sites, Cys402, Cys403 and Cys405 (Okamoto et al., 1997). In the case 
of the ETB receptor, this covalent modification appears to be constitutive, i.e. occurs 
without agonist stimulation (Okamoto et al., 1997), whereas for some other rhodopsin-
like GPCRs, β2 adrenergic receptor for example, it is caused by agonist stimulation 
(Moffet et al., 1993).  
 
Experiments with [
3H] palmitic acid incorporation showed that out of three potential 
palmitoylation sites in ETB, only two are palmitoylated. An unpalmitoylated triple ETB 
receptor mutant, when expressed in CHO cells, appeared on the cell surface, and 
retained high affinities toward the ligand. However, unlike the wild-type receptor, the 
mutant one transmitted neither an inhibitory effect on adenylate cyclase nor a 
stimulatory effect on phospholipase C (Okamoto et al., 1997), indicating a critical role 
of palmitoylation in the coupling with G proteins. 
 
A newly discovered ETB receptor splice variant (Elshourbagy et al., 1996), with a 
substantially shorter C-terminus and lacking palmitoylation sites, retained ligand 
binding capacity when expressed, but lacked the ability to activate G protein. This 
finding is in accordance with the conclusions about the role of palmitoylation in G 
protein coupling, and also in accordance with the role of the splice variant as a 
clearance receptor for endothelin, whose further fate is to be internalized upon binding 
a ligand and targeted to lysosymes for degradation. 
 
1.3.3.2     ETB receptor ligand binding domain 
 
Because the 3D structure of ETB is not yet available, various chemical and molecular 
biological approaches have been employed to study the ligand binding domain (LBD) of the 
ETB receptor. Monitoring the ligand binding activity of truncated mutants of ETB defined the 
ligand binding domain as the 60 amino acid sequence between Ile138 and Ile197 (Wada et al., 
1995). Additionally, it was found that part of the N-terminus, in close proximity to the first 
transmembrane helix, was required for the ligand binding activity as well. Interestingly, it 
seems that 12 amino acids from the C-terminus of the receptor are necessary to maintain LBD 
in an active form (Wada et al., 1995). 
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1.4  Different expression systems for GPCR production 
 
Determining the three-dimensional structure of a protein requires milligram quantities of pure 
material. Historically, the structure determination of a protein was limited to those naturally 
abundant in certain tissues or cell sources. With the development of molecular cloning and 
gene expression techniques however, even proteins constitutively present in minute amounts 
can be produced in heterologous systems, purified and subjected to structural analyses.  
GPCRs are proteins that are naturally expressed in very low amounts (there are exceptions to 
this rule, like rhodopsin, which is highly abundant and very densely packed in retinal 
membranes). A second problem encountered is the heterogeneity of receptor isolated from 
native tissue, i.e. the presence of different receptor subtypes. In most cases, heterologous 
expression of the receptor allows the analysis of a single receptor subtype in a defined system 
and provides the possibility of obtaining it in quantities large enough for structural studies. 
However, the choice of a suitable host is not an easy task – one has to bear in mind that 
GPCRs are membrane proteins and that they require the proper surroundings for correct 
folding and insertion into the membrane lipid bilayer. Furthermore, they are quite different 
from soluble proteins in that they are largely hydrophobic. In addition, they can bear a 
number of complex post-translational modifications. All of these factors must be taken into 
account when choosing the appropriate host for overexpression of GPCRs. Additionally, it is 
important to decide if the amount of the protein is what is important, in which case the 
inexpensive and easy-to-handle E. coli and yeast expression systems are preferred, or if a 
protein virtually identical to the one from the natural source, with all the posttranslational 
modifications, is needed, in which case the mammalian and insect cells are the expression 
systems of choice.  
 
1.4.1 E.  coli  as a host for protein production 
 
The extensive range of expression vectors available, detailed knowledge about its genetics 
and ease of manipulation render E. coli usually the first expression system of choice for 
protein overexpression. 
However, heterologously produced membrane proteins are often toxic to E. coli, which 
prevents cell growth and limits yield. Misfolding, aggregation, improper transport and 
insertion into the membrane are further problems researchers are facing when trying to 
produce a eukaryotic membrane protein in E. coli. Milligram quantities of membrane proteins 
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have been obtained only after different tactics were employed, to produce them in the form of 
inclusion bodies. Proteins derived from inclusion bodies are mostly misfolded aggregates and 
have to be refolded to the native state. This has been successful for many soluble, but only for 
a few membrane proteins (reviewed in Grisshammer and Tate, 1995).  In the case of GPCRs, 
much effort has been put into their production in E. coli, with unsatisfactory results: there are 
only a few reports so far of successful expression in inclusion bodies&proper refolding, 
yielding a GPCR capable of binding a ligand. One example is an olfactory receptor, expressed 
as a fusion protein with glutathione-S-transferase (Kiefer et al., 1996). However, there are 
several reports of functionally active GPCRs expressed in E. coli as fusions with maltose-
binding protein and inserted in the bacterial membrane: the rat neurotensin  (Grisshammer et 
al., 1993) and NK-2 receptor (Grisshammer et al., 1994), the human ETB receptor (Haendler 
et al., 1993), and the human adenosine A receptor (Weiss and Grisshammer, 2002). 
Generally, the yield of GPCRs in this expression system is low (0.1 mg/L culture) and there is 
no possibility of in vivo post-translational modification.  
 
1.4.2 Mammalian  cells 
 
Mammalian cells provide the most authentic background (most natural environment) for the 
expression of GPCRs. Producing mammalian protein in a mammalian expression system has 
the distinct advantage that the post-translational modifications are efficiently performed, 
resulting in a high percentage of functional protein produced in the cases where these 
modifications are of importance for protein function. This is the main reason that mammalian 
cells are the preferred expression system in the pharmaceutical industry for high throughput 
drug screening. 
There are three different approaches to protein production in mammalian cells: transient 
expression, cell infection by recombinant viruses and expression in stable cell lines. However, 
classical transient expression and cell lines are not very convenient for GPCR expression on a 
large scale. Transient expression is difficult to scale up, often with the problem that only a 
subset of the cells is transfected. Conventional stable cell lines are rather time-consuming to 
establish, and stability problems occur frequently, since the gene expression cassette 
integrated into the host cell genome can be deleted or otherwise inactivated.  
An alternative method for the transient expression of foreign proteins in mammalian cells is 
provided by recombinant viruses. High infection efficiency in a broad range of host cells is 
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the main advantage of this system. The replication-deficient alpha viruses Semliki Forest 
virus and Sindbis virus have been used successfully so far. 
 
1.4.2.1     Semliki Forest virus (SFV) 
 
Alpha viruses such as SFV are small enveloped viruses with a single-stranded RNA genome. 
Liljestrom&Garoff developed SFV expression vectors specifically for the purpose of 
producing high levels of recombinant proteins in mammalian cells (Liljestrom and Garoff, 
1991). The target DNA is cloned into an SFV plasmid vector, which contains SFV non-
structural genes (nsP1-4), the strong SFV 26S promoter and a multi-cloning region for 
introduction of foreign genes. This vector serves as a template for in vitro synthesis of 
recombinant RNA. SFV structural proteins are provided by the helper vector, containing the 
capsid and envelope genes needed for virus particle packaging. Therefore, RNA transcripts 
from both vectors have to be cotransfected into the cell by electroporation in order to obtain 
new virus particles (Fig 1.8). Due to the presence of an RNA packaging signal only in the 
recombinant RNA, no helper RNA will be packaged, which renders the generated particles 
replication deficient. Since this virus has a very broad host range and high infectivity, 
extremely stringent biosafety standards must be met. To address this issue, a system for 
production of conditionally infectious, replication deficient recombinant particles has been 
established (Berglund et al., 1993). The additional safety precaution is that the new virus 
particles released from the cell have to be activated by a protease (α-chymotrypsin) to be 
rendered infectious. Activated virus particles are then used as virus stocks for infection of 
different kinds of mammalian host cells.  
 
Thus far more than 50 GPCRs have been successfully expressed using this system (reviewed 
in Lundstrom et al., 2001, Lundstrom, 2003). Many of them, like the human neurokinin-1 
receptor (Lundstrom et al., 1994), adrenergic α1b, α2b and β2 (Bjorklof et al., 2002) and 
histamine receptors (Hoffmann et al., 2001) have been produced in rather high amounts, 
ranging between 50 - 150 pmol/mg. The system can potentially be scaled up for production of 
large quantities of recombinant receptors in mammalian suspension cell cultures, amenable to 
structural studies. 
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Fig 1.8      The SFV expression system  
 
 
1.4.3  Insect cells/baculovirus system 
 
The well-established technology of the baculovirus/insect cell system exploits the biological 
properties of the Autographica californica nuclear polyhedrosis virus (baculovirus) that 
permits the homologous recombination of foreign genes into a specific locus of its genome. In 
most cases, the target of recombination is the polyhedrin locus, polyhedrin being a non-
essential protein produced at extremely high levels in very late stages of viral infection.  The 
very late polyhedrin promotor is the most widely used to drive heterologous protein 
expression. This yields recombinant viruses that can infect a variety of insect cell lines. The 
cell line most often used is the Sf9, an ovarian cell derivative from the butterfly Spodoptera 
frugiperda. 
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The main advantage of the baculovirus expression system is that it expresses GPCRs in a 
functional form, and sometimes at very high levels. In particular, some GPCRs have been 
expressed to levels of 10-100 pmol/mg. These include the β-adrenergic, serotonine, 
muscarinic, dopamine and chemokine receptors (reviewed in Bouvier et al., 1998). However, 
particularly high overexpression leads to the saturation of the biosynthetic pathway of the Sf9 
cell, resulting in a portion of the expressed receptor being trapped in the ER or Golgi 
apparatus in an inactive form. To circumvent this problem, purification strategies should 
contain a step based on the biological activity of the receptor, such as ligand affinity 
chromatography, in order to obtain a homogeneous and active protein sample. 
 
The major advantages of insect cell/baculovirus system can be summarised as follows: 
•  High-level production of mostly functional GPCR 
•  GPCRs expressed in insect cells are often poorly glycosylated, resulting in a more 
homogeneous protein sample 
•  Insect cells are capable of performing other post-translational modifications required 
for the correct folding and function of expressed mammalian proteins 
•  Insect cells (Sf9) are deficient in endogenous GPCRs (Butkerait et al., 1995), 
providing a low-background environment for functional assays on heterologously 
expressed GPCRs, but they still contain a small number of G proteins  
  
1.4.4 Yeasts 
 
Yeasts are unicellular eukaryotes and they offer the advantage of a eukaryotic host in that they 
are able to perform the post-translational modifications observed in mammalian cells. In 
addition, they provide an inexpensive, easily scalable expression system for obtaining large 
amounts of protein. 
However, there are several problems inherent to this specific expression host that must be 
noted, but are possible to overcome. On of them is that the receptors expressed often remain 
in internal membrane compartments instead of going to the plasma membrane, which can be 
circumvented by using N-terminal fusions with a leader peptide (Arkinstall et al., 1995; 
Weiss et al., 1995) or with the N terminus of the yeast α factor receptor STE2 (King et al., 
1990). Proteolytic degradation of GPCRs is another problem, and can be alleviated by using 
protease-deficient yeast strains for expression (Sander et al., 1994). It should also be noted 
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that the lipid composition of yeast membranes differs from that of mammalian ones, which 
can lead to altered ligand-binding properties for some GPCRs (Sander et al., 1994). 
However, recently a large number of GPCRs has been expressed successfully and in high 
yield in S. pombe, H. polymorpha and especially P. pastoris (for an extensive list, see Craig 
and Cereghino, 2000). This has given legitimacy to the choice of this expression system for 
producing GPCRs for structural studies. 
Since in this work P. pastoris was used as a host to overexpress the endothelin B receptor, its 
features will be presented in more detail in the next section. 
 
1.4.4.1     The P. pastoris expression system 
 
The story of P. pastoris begins thirty years ago, when Koichi Ogata first described the ability 
of certain yeasts to utilize methanol as a source of carbon and energy (Ogata et al., 1969). 
These methylotrophs attracted immediate attention as potential sources of single-cell protein 
(SCP), to be used as high-protein animal feed. In the early seventies, Phillips Petroleum 
Company developed media and protocols for cultivating P. pastoris on methanol at high 
densities. Soon after, the idea concerning animal feed was abandoned for economic reasons, 
but the company contracted with the Salk institute of Biotechnology in California and 
continued developing the P. pastoris system for heterologous protein expression. The 
expression system has been commercially available from the Invitrogen company since 1993. 
P. pastoris is methylotrophic yeast, capable of metabolizing methanol as its sole carbon 
source. The first step in the catabolism of methanol is the oxidation of methanol to 
formaldehyde. This step is catalysed by the enzyme alcohol oxidase (Douma et al., 1983). 
Since this enzyme has a poor affinity for oxygen (Km 0,1-1,0 mM) (Couderc and Baratti, 
1980), the yeast cell compensates this by generating large amounts of the enzyme. Besides 
formaldehyde, the reaction also generates hydrogen peroxide, which is highly toxic to the cell. 
For this reason, oxidation takes place in the peroxisome.  
Two genes in P. pastoris code for alcohol oxidase – AOX1 and AOX2, the former accounting 
for 95% of the enzyme in the cell. Expression of the AOX1 gene is tightly regulated and 
strongly induced by methanol (typically representing 30% or more of the total soluble protein 
in cells grown on methanol). For this reason, the promoter of the AOX1 gene is used to drive 
heterologous protein expression in Pichia (Tschopp et al., 1987; Koutz et al., 1989).  
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Heterologous protein in P. pastoris can be produced either intracellularly or secreted (rev. in 
Cereghino and Cregg, 2000). Secretion requires the presence of a signal peptide on the protein 
produced in order to target it to the secretory pathway. The most widely used signal peptide 
for this purpose is the secretion signal peptide from the Saccharomyces cerevisiae α factor 
prepro-peptide (Cregg et al., 1993). 
The major advantages of the P. pastoris expression system: 
•  Using the strong AOX1 promoter, it is possible to achieve high levels of foreign 
protein expression – 30% of the total cell protein  
•  P. pastoris can be fermented to very high densities (up to 500 g wet weight/L), owing 
to its preference for respiratory growth and the fact that it is a poor fermenter (won’t 
“pickle” itself in ethanol!) 
•  The cloned insert with the gene of interest is stably integrated into the yeast genome. 
Furthermore, it is possible to select clones containing multiple inserts of the gene  
•  Speed and ease of manipulation – P. pastoris expression vectors are designed as 
E.coli/P.pastoris “shuttle” vectors, i.e. they posses the ColE1 origin of replication, 
which enables their cloning and amplification in E. coli 
•  P. pastoris is capable of performing posttranslational modifications (glycosylation, 
phosphorylation, palmitoylation and disulphide bond formation) 
•  There is no hyperglycosylation of the expressed protein, as with S. cerevisiae 
 
P. pastoris has already proven to be a suitable host for GPCR overexpression – the β2 
adrenergic receptor (Weiss et al., 1998), µ opioid receptor (Talmont et al., 1996) and 
5HT5A serotonine receptor (Weiss et al., 1995) have already been expressed successfully 
in this system. 
The most common problem with P. pastoris is proteolytic degradation of the target 
protein and the usage of protein deficient strains SMD1163 and SMD1168 is highly 
recommended. In this work, the strain SMD1163 was used, which has mutations in two 
protease genes and shows substantial reduction in three protease activities. 
  
1.5  Aim of the work 
 
The goal of this work was to produce large quantities of active endothelin B receptor  (ETB) 
and to optimize its purification in order to obtain protein sample amenable for crystallization 
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trials. Despite receptor overproduction in a suitable host, a purification factor of more than 
1000 has to be achieved. To minimize the loss of protein, this should be done in as few steps 
as possible, which can be accomplished only by affinity chromatography. Receptor fusions 
with different peptides (“affinity tags”) were produced and different purification strategies 
tried out in order to find most suitable one for scaling up. 
Three different hosts for protein production were to be tested and compared for receptor 
overproduction: yeast Pichia pastoris, insect cells/baculovirus system and mammalian 
cells/Semliki Forest virus system. 
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2  Materials and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals 
General chemicals used in this work and not listed here were ultra pure chemicals p.A. grade 
from the companies Sigma-Aldrich Chemie GmbH, Deisenhofen, Carl Roth&Co. KG, 
Karlsruhe or from Merck KgaA, Darmstadt. 
 
Acrylamide ready-made solution     Carl Roth GmbH&Co. KG, Karlsruhe 
for polyacrylamide gels 
Agarose, electrophoresis grade    Bethesda Research Laboratories GmbH,  
Neu Isenburg 
Ammonium-persulfate (APS)    Serva  Elektrophoresis GmbH, Heidelberg 
Ampicillin, sodium salt      Carl Roth GmbH&Co. KG, Karlsruhe 
Bacto Agar          Difco Laboratories, Detroit, Michigan, USA 
Bacto  Tryptone     Difco  Laboratories, Detroit, Michigan, USA 
Bacto  Yeast  Extract     Difco  Laboratories, Detroit, Michigan, USA 
Biotin       Serva  Elektrophoresis  GmbH,  Heidelberg 
Bovine serum albumin (BSA)    Sigma-Aldrich Chemie GmbH, Deisenhofen 
5-Bromo-4-chloro-3-indolylphosphate, Biomol Feinchemikalien GmbH, Hamburg 
4-toluidine salt (BCIP) 
Bromophenol  blue     Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Coomassie Brilliant Blue R-250    Serva Elektrophoresis GmbH, Heidelberg 
Concanavalin  A     Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Deoxynucleoside-5’-triphosphates    Pharmacia Biotech, USA 
(dATP, dGTP, dTTP, dCTP) 
1,4-dithiothreitol (DTT)      Serva Elektrophoresis GmbH, Heidelberg 
Ethidium-bromide     Bio-Rad  Laboratories  GmbH,  Munich 
Ethylenediaminetetraacetic acid    GERBU Biotechnik GmbH, Gaiberg 
(disodium salt) (EDTA) 
Geniticin sulfate G418      Novabiochem GmbH, Bad Soden/Ts. 
Glass beads (0.5 mm)       Biomatik GmbH, Frankfurt 
Glutaraldehyde     Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
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Glycine      Serva  Elektrophoresis  GmbH,  Heidelberg 
Kanamycin      Carl  Roth  GmbH&Co.  KG,  Karlsruhe   
Non-fat  milk  powder       Carl Roth GmbH&Co. KG, Karlsruhe 
N,N,N’N’-tetramethylethyldiamine   Sigma-Aldrich Chemie GmbH, Deisenhofen 
(TEMED) 
Nitrobluetetrazolium, toluidine salt    Biomol Feinchemikalien GmbH, Hamburg 
(NBT) 
Peptone      Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Phenol       Carl  Roth  GmbH&Co.  KG,  Karlsruhe 
Polyethyleneglycol  6000    Serva  Elektrophoresis GmbH, Heidelberg 
Polyethyleneimine  (PEI)    Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Silver nitrate (AgNO3)    Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Streptavidine-AP  conjugate    Amersham Buchler GmbH&Co, Braunschweig 
Tetracycline-hydrochloride    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Tris-(hydroxymethyl)-aminomethane Carl Roth GmbH&Co. KG, Karlsruhe 
Tunicamycin      Sigma-Aldrich  Chemie  GmbH,  Deisenhofen 
Yeast Nitrogen Base (YNB), w/o    Difco Laboratories, Detroit, Michigan, USA 
amino acids, w/o ammonium-sulfate 
 
2.1.2  Radioactive labelled chemicals 
[
125I]Tyr
13-Endothelin 1            NENLife Science Products,  
(human,  porcine)      Inc.  Boston,  USA 
 
2.1.3 Detergents 
Sodium-dodecyl-sulfate (SDS)         Carl Roth GmbH&Co. KG, Karlsruhe 
Digitonin               Sigma-Aldrich Chemie GmbH, Deisenhofen 
Deoxycholate, sodium salt           Sigma-Aldrich Chemie GmbH, Deisenhofen 
n-Dodecyl-β-maltoside (LM)          Glycon Biochemicals, Luckenwalde  
n-Decyl-ß-maltoside (DM)           Glycon Biochemicals, Luckenwalde 
n-Undecyl-ß-maltoside (UM)         Glycon Biochemicals, Luckenwalde 
n-Octyl-ß-D-glucopyranoside (OG)                   Glycon Biochemicals, Luckenwalde 
N-dodecylphosphocholine, Fos12          Anatrace, Maumee, OH, USA 
N-tetradecylphosphocholine, Fos14         Anatrace, Maumee, OH, USA     
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N-hexadecylphosphocholine, Fos16        Anatrace, Maumee, OH, USA 
Tween 20               Koch-Light Ltd., Haverhill, England 
 
2.1.4 Protease  inhibitors 
Aprotinin                 Biomol Feinchemikalien GmbH, Hamburg 
Benzamidine                 Sigma-Aldrich Chemie GmbH, Deisenhofen 
Leupeptin                 Calbiochem GmbH, Bad Soden 
Pepstatin A                 Serva Elektrophoresis GmbH, Heidelberg 
Phenylmethylsulfonylfluoride (PMSF)         Carl Roth GmbH&Co. KG, Karlsruhe 
Complete, EDTA free             Roche Diagnostis GmbH, Mannheim 
E64                   Biomol Feinchemikalien GmbH, Hamburg 
 
2.1.5  Chromatographic matrices and prepacked columns 
Anti-Flag M2 Affinity Gel            Sigma-Aldrich Chemie GmbH, Deisenhofen 
ImmunoPure Immobilized Monomeric         Pierce, Rockford, USA 
Avidin Gel 
Ni-NTA  matrix                Qiagen GmbH, Hilden 
Superose 6 PC 3.2/30              Amersham Pharmacia Biotech, Freiburg 
UltraLink Immobilized Monomeric         Pierce, Rockford, USA 
Avidin Gel 
MicroSpin S-200 HR prepacked columns        Sigma-Aldrich Chemie GmbH, Deisenhofen 
Streptavidin-coated magnetic agarose beads       Dynal, Hamburg 
                  
2.1.6 Enzymes 
Restriction endonucleases              MBI Fermentas GmbH, St. Leon-Rot and 
                    New England Biolabs GmbH, Schwalbach 
T4 DNA ligase                New England Biolabs GmbH, Schwalbach 
T4 DNA polymerase                MBI Fermentas GmbH, St. Leon-Rot 
Benzonase                  Merck KgaA, Darmstadt 
SP6 RNA polymerase                MBI Fermentas GmbH, St. Leon-Rot 
 
2.1.7 Antibodies 
Anti-Flag M2 monoclonal antibody           Sigma-Aldrich Chemie GmbH, Deisenhofen 
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Anti-Mouse IgG, AP conjugated             Sigma-Aldrich Chemie GmbH, Deisenhofen 
Monoclonal anti-polyhistidine antibody           Sigma-Aldrich Chemie GmbH, Deisenhofen 
 
2.1.8 Kits 
Qiagen Plasmid miniprep kit       Qiagen GmbH, Hilden 
QIAquick Gel Extraction kit    Qiagen  GmbH,  Hilden 
QIAquick PCR Purification kit      Qiagen GmbH, Hilden 
HiSpeed Plasmid Maxi kit        Qiagen GmbH, Hilden 
BCA Protein Assay Kit        Pierce, Rockford, USA 
 
2.1.9 Marker  proteins 
SDS-6H High Molecular Weight Markers                Sigma-Aldrich GmbH, Deisenhofen 
SeeBluePlus2 Pre-Stained Protein standard  Invitrogen GmbH, Karlsruhe 
 
2.1.10   Buffers and Solutions 
Agarose  gel  (1%)      1g  agarose   
       100  ml  1xTAE  buffer 
       2.5  µL EtBr (10mg/mL) 
Ampicillin stock solution (1000x)      150 mg/mL in H2O (sterile filtered, stored   
                                                                                                                         at -20°C) 
AP  buffer       100  mM  Tris/HCl,  pH  9.5 
       100  mM  NaCl 
             5   m M   M g C l 2 
Aprotinin  (40x)      20  mg/mL  in  PBS 
A P S         1 0 %   ( w / v )   i n   H 2O    
BCIP-solution       50  mg  BCIP/mL  DMF  (stored  at  –20°C) 
Benzamidine  (100x)      100  mM  in  H2O 
Binding  buffer     50  mM  Na2HPO4, pH 7.4 
       500  mM  NaCl 
       5   m M   E D T A  
       0.1%  BSA 
Coomassie solution          1.25 g Coomassie Brilliant Blue R250 
       200  mL  H2O 
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       50  mL  acetic  acid 
       250  mL  methanol 
Conditioner  (silver  gels)     400 mM sodium-acetate, pH 6.0 
       0.5  %  (v/v)  glutaraldehyde 
       0.1%  (w/v)  Na2S2O3 
       30%  (v/v)  ethanol 
Destaining solution (Coomassie gels)    1 L methanol 
       1   L   H 2O 
       200  mL  acetic  acid 
Developer  (silver  gels)     2.5%  (w/v)  Na2CO3 
       0.04%  (v/v)  formaldehyde 
Fixier  (silver  gels)      30%  ethanol 
       1 0 %   a c e t i c   a c i d  
Kanamycin stock solution        30 mg/mL in H2O, stored at –20°C 
Leupeptin  (500x)      0.25  mg/mL  in  H2O 
Loading buffer 4x (SDS PAGE)      0.25 mM Tris/HCl, pH 6.8 
       4 0 %   ( w / v )   g l y c e r o l  
       20%  (v/v)  ß-mercaptoethanol 
       8 %   ( w / v )   S D S  
       0.004%  (w/v)  bromophenol  blue 
Loading buffer (DNA)        50 mM Tris/HCl, pH 7.4 
       5   m M   E D T A  
       50%  (v/v)  glycerol 
       0.05%  (w/v)  bromophenol  blue 
NBT solution           50 mg NBT/mL in  70% DMF,  
stored at 4°C 
Pepstatin  A  (500x)      0.35  mg/mL  in  methanol 
PMSF  (200x)/(500x)      200mM  in isopropanol/500 mM in DMSO 
Running buffer 10x (SDS PAGE)      500 mM Tris 
       1.92  M  glycine 
       1 %   ( w / v )   S D S  
 
rNTP  mix         10  mM  ATP 
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       1 0   m M   C T P  
       1 0   m M   U T P  
           5   m M   G T P  
 
Staining solution (silver gels)   0.1%  (w/v)  AgNO3 
       0.025%  (v/v)  formaldehyde 
TAE  buffer  (50x)      2  M  Tris 
       1  M  acetic  acid 
       50  mM  EDTA,  disodium  salt 
TBS  buffer       50  mM  Tris/HCl,  pH  7.4 
       150  mM  NaCl 
TBST  buffer       10  mM  Tris/HCl,  pH  8.0 
       150  mM  NaCl 
Tetracycline stock solution        12.5 mg/mL in 50% ethanol,  
stored at –20°C 
Transfer buffer 1x (Immunoblot)      38 mM glycine 
       1 0   m M   T r i s  
       20%  (v/v)  methanol 
Transfer buffer 5x (Immunoblot)      190 mM glycine 
       5 0   m M   T r i s  
 
2.1.11     Primers for sequencing 
Primers for sequencing for pPIC9K vector: 
αfor : 5’ – CTA CTA TTG CCA GCA TTG CTG C – 3’ 
AOX1rev :  5’ – GGC AAA TGG CAT TCT GAC ATC C – 3’ 
Primers for sequencing for pSFV3CAP vector: 
CAPfor :  5’ - CTG TCG GTG GTC ACC TGG - 3’ 
EtBRCTfor :  5’ – CTG AAT TCC TGC ATT AAC CC – 3’ 
 
2.1.12     Oligonucleotides 
Streptagfor: 5’ –AA TTC TCT GCT TGG AGA CAT CCA CAA TTT GGT GGT 
TAA GC – 3’ 
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Streptagrev:  5’ – GGC CGC TTA ACC ACC AAA TTG TGG ATG TCT CCA AGC 
AGA G – 3’ 
StreptagIIfor: 5’ – AA TTC TCT GCT TGG TCT CAT CCA CAA TTT GAA AAG 
TAA GC – 3’ 
StreptagIIrev: 5’ – GGC CGC TTA CTT TTC AAA TTG TGG ATG AGA CCA AGC 
AGA G – 3’ 
 
2.1.13    Bacterial and yeast strains 
E. coli strain XL1-Blue:  endA1, hsdR17 (rk-, mk+); supE44, thi-1, λ−, recA1, gyrA96,  
                                                relA1, ∆(lacZYA-argF)U169 [F’: proAB, lacI
qZ∆M15,    
                                               Tn10(Tet
r )], Stratagene GmbH, Heidelberg  
Pichia pastoris yeast strain: 
SMD1163: Mut
+ , His
-, protease-deficient (his4, pep4, prb),                        
Invitrogen Inc., San Diego 
 
2.1.14    Media for bacterial cultures 
LB medium 
Bacto Tryptone    10 g/L 
Bacto Yeast Extract      5 g/L 
NaCl         5  g/L 
Bacto Agar      15 g/L (for the plates) 
SOB medium 
Bacto Tryptone    20 g/L 
Bacto Yeast Extract      5 g/L 
NaCl                  10 mM 
KCL     2.5  mM 
SOC medium 
Bacto Tryptone    20 g/L 
Bacto Yeast Extract      5 g/L 
NaCl                10 mM 
KCL                2.5 mM 
MgCl2               10 mM 
MgSO4              10 mM 
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Glucose              20 mM 
 
FSB (Frozen storage buffer) 
Sodium-acetate   10  mM 
Glycerol    10%  (w/v) 
KCl                  100 mM 
MnCl2x4H2O    45  mM 
CaCl2x2H2O    10  mM 
HACoCl3    3  mM 
 
2.1.15    Media for yeast cell cultures 
Fermentation medium 
Basic salt medium    0.93 g CaSO4x2H2O 
(per liter):      18.2 g K2SO4 
    14.9  g  MgSO4x7H2O 
             9 g (NH4)2SO4 
           40 g glycerol 
Fill with H2O to 900 mL and autoclave in the fermenter vessel. Make separately the solution 
of Na-hexametaphosphate – dissolve 25 g of the salt in 100 mL H2O and sterile filtrate. Add 
this solution to the cold and sterile fermenter medium, as well as 4.35 mL of  PTM1 trace 
element stock solution, via sterile tubing. 
Stock solutions  
Potassium phosphate buffer (10x)    1M KH2PO4 in H2O,  
adjust pH to 6.0 with KOH and autoclave 
Yeast nitrogen base (YNB) (10x)    34  g YNB w/o amino acids, w/o ammonium-
sulfate, 100 g ammonium-sulfate. Dissolve in 1 L 
H2O, sterile filter and store at 4°C 
Methanol (10x)    5 mL of methanol in 95 mL of sterile H2O 
    Store at 4°C, max. 2 months 
Biotin (500x)  Dissolve 20 mg of biotin in 100 mL H2O, sterile 
filter and store at 4°C 
Geniticin sulfate G418   50 mg/mL, sterile filtrate, store at –20°C 
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Glucose (10x)  Dissolve 200 g D-glucose in 1L H2O, autoclave 
for 15 min, store at RT 
Glycerol (10x)    Mix 100 mL glycerol with 900 mL of H2O, 
autoclave and store at RT 
PTM1 trace salt solution for the fermentation 
    0.2 g biotin 
    0.5 g CoCl2 
  6 g CuSO4x5H2O 
  65 g Fe(II)SO4x7H2O 
  0.02 g H3BO3 
 5  mL  H2SO4 
  3 g MnSO4xH2O 
  0.08 g NaI 
  0.2 g Na2MoO4 
  20 g ZnCl2 
  Fill till 1L with H2O, sterile filter and store at RT 
for max. 6 months 
Media: 
BMGY medium 
Dissolve 20 g peptone and 10 g Bacto Yeast Extract in 700 mL H2O, 20 min autoclave. When 
it cools down to 60°C ,   a d d :         
100 mL potassium-phosphate buffer (10x) 
      100  mL  YNB  (10x) 
      2  mL  biotin  (500x) 
100 mL glycerol (10x) 
and store at 4°C max. 2 months. 
BMMY medium 
Dissolve 20 g peptone and 10 g Bacto Yeast Extract in 700 mL H2O, 20 min autoclave. When 
it cools down to 60°C, add: 
100 mL potassium-phosphate buffer (10x) 
      100  mL  YNB  (10x) 
      2  mL  biotin  (500x) 
100 mL methanol (10x) 
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      a n d   s t o r e   a t   4 °C max. 2 months 
YPD medium 
Dissolve 20 g peptone and 10 g Bacto Yeast Extract in 900 mL H2O and autoclave for 20 min. 
When it cools down to 60°C, add: 
      100  mL  glucose  (10x) 
      S t o r e   a t   4 °C max. 2 months 
YPD plates 
Dissolve 20 g peptone, 10 g Bacto Yeast Extract and 20 g Bacto agar in 900 mL H2O and 
autoclave for 20 min. When it cools down to 60°C, add: 
      100  mL  glucose  (10x) 
      S t o r e   a t   4 °C max. 2 months 
YPD-G418 plates 
Dissolve 20 g peptone, 10 g Bacto Yeast Extract and 20 g Bacto agar in 900 mL H2O and 
autoclave for 20 min. When it cools down to 60°C, add: 
      100  mL  glucose  (10x) 
      Geniticin  sulfate  G418  in  desired  concentration 
      S t o r e   a t   4 °C max. 2 months 
 
2.1.16    Chemicals & media for insect&mammalian cell cultures 
Sf9  cells           American  Type  Tissue  Collection, 
       M a n a s s a s ,   U S A  
TNM-FH  medium        ccPro,  Neustadt 
FKS        GibcoBRL,  Life  Technologies  GmbH, 
    Karlsruhe   
L-glutamine        GibcoBRL,  Life  Technologies  GmbH, 
    Karlsruhe   
Gentamycin       ccPro,  Neustadt    
Vitamin  B12       Sigma  Chemie  GmbH,  Deisenhofen 
Pluronic-68         Sigma  Chemie  GmbH,  Deisenhofen 
BHK  cells       European  Collection  of  Cell  Cultures,  UK 
CHO  cells       Aventis  Pharma,  Frankfurt  am  Main 
Dulbecco’s modified Eagle’s medium (DMEM)  Cell Concepts, Umkirch, Germany  
Iscove’s  medium        Cell  Concepts,  Umkirch,  Germany 
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Trypsin-EDTA      Cell  Concepts,  Umkirch,  Germany 
CAP        New  England  Biolabs  GmbH,  Schwalbach 
 
2.1.17   Apparatus-general 
Cell mill Dynomill KDL A      Willy A. Bachofen, Switzerland 
Electroporation device    Biorad,  Munich 
Microscope      Olympus  Inc.,  Japan 
Shakers      Infors  AG,  Bottmingen,  Switzerland 
Spectrophotometer     Thermo Spectronic, Cambridge, UK 
Vortexer      Bender&Hobein  AG,  Zürich,  Switzerland 
Thermomixer  5436     Eppendorf  GmbH,  Hamburg 
 
2.1.18   Centrifuges 
Sorvall  RC-5B    Sorvall,  Bad  Homburg 
Avanti  J-20  XPI     Beckman-Coulter, Fullerton, CA, USA 
Optima LE-80K ultracentrifuge    Beckman-Coulter, Fullerton, CA, USA 
Tabletop ultracentrifuge TL100    Beckman Instruments Inc., Palo Alto,USA 
Microfuge  5415D     Eppendorf  GmbH,  Hamburg 
Sigma 3K 12 tabletop centrifuge    Sigma-Aldrich Chemie GmbH, Deisenhofen 
 
2.1.19   Filters 
GF/C filters for binding assay    Whatman Intl. LtD, Maidstone, England 
Prefilters  AP25     Millipore  GmbH,  Eschborn 
1,2 µM membranes RA      Millipore GmbH, Eschborn 
0,45 µM membranes HA      Millipore GmbH, Eschborn 
Net  AP32      Millipore  GmbH,  Eschborn 
MediaKap-filters 2L and 5L     INTEGRA  Biosciences  Germany 
Small filters 0,22 µm and 0,45 µm    Schleicher&Schuell GmbH, Dassel 
 
2.1.20   Fermenter  and  equipment 
10 L Bioreactor, magnetic stirrer, pH-  New Brunswick Scientific, Edison, NJ, USA 
and O2-electrode, thermometer, 
and computer control unit 
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Methanol detector and sensor unit    Raven Biotech Inc., Vancouver, Canada 
Pump Watson-Marlow 101U/R    Smith and Nephew Watson-Marlow 
      Falmouth,  England 
 
2.2 Methods 
 
2.2.1  E. coli cultivation 
For the overnight culture of E. coli XL1Blue, one single colony was picked from an LB agar 
plate and inoculated into 5 mL of LB medium with tetracycline (12.5 µg/mL final 
concentration). The culture was incubated overnight at 37°C and 225 rpm.  
Large (50-100 mL) E. coli cultures were prepared from the small overnight pre-culture. LB 
medium with the antibiotic was inoculated 1:100 with the overnight pre-culture. 
 
2.2.2  Preparation of competent cells  
Competent E. coli cells were prepared according to the TFB based chemical transformation 
protocol in DNA cloning 1 – A Practical Approach (Eds. Glover&Hames). Briefly, E. coli 
XL1 Blue cells were grown in 50 mL of SOB medium overnight. The cells were then chilled 
on ice for 15 min, pelleted for 15 min at 1000xg and resuspended in 1/3 of the culture volume 
of TBF. Following resuspension, the cells were incubated on ice. Afterwards, the cells were 
pelleted (1000g, 4°C, 15 min), and resuspended in 1/12.5 of the original culture volume of 
FSB. DMSO was added (7 µL to 200 µL suspension) and the suspension swirled with a 
pipette. The cells were incubated on ice for 5 min, a second aliquot of DMSO added, followed 
by a 15 min incubation on ice. The suspension was aliquoted 200 µL each in pre-cooled 1.5 
mL-Eppendorf tubes and flash frozen in liquid nitrogen. The aliquots were stored at –80°C. 
 
2.2.3  Plasmid DNA transformation into competent E. coli cells 
Competent E. coli cells were thawed on ice and 200 µL of cell suspension was mixed with 10 
µL of the ligation reaction (s. 2.2.8). After 30 min incubation on ice, the suspension was 
subjected to heat shock at 42°C for 2 min. Afterwards 800 µL of LB medium was added and 
the cells were incubated 45-60 min at 37°C with shaking. 100 µL of the suspension was 
plated on an LB plate containing the appropriate antibiotic and the plate incubated overnight 
at 37°C. 
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2.2.4  Fast plasmid DNA transformation after Hanahan (1983) 
This method is suitable only for fast transformation of relatively highly concentrated plasmid 
DNA (>5µg/mL).  
A clump of E. coli colonies was picked from an LB agar plate and transferred to 200 µL of 
ice-cold FSB buffer. The cells were resuspended by vortexing and then incubated for 10 min 
on ice. 10-1000 ng of plasmid DNA (<10µL) was added to the cell sample, mixed with the 
pipette tip and incubated for further 10 min on ice. After the heat shock at 42°C for 90 s, 800 
µl of SOC medium was added. The sample was then incubated for 30 min at 37°C with 
shaking (this step was optional when more than 100 ng of DNA was used for transformation). 
Different amounts of cells were then plated on the LB agar plates containing the appropriate 
antibiotic and the plates incubated overnight at 37°C. 
 
2.2.5 DNA  isolation 
Isolation of plasmid DNA from E. coli and isolation of DNA fragments were carried out 
following the instructions manual from the relevant QIAGENE kit. 
 
2.2.6 Phenol-chloroform  extraction 
The procedure developed by Brawerman (1972) is used for removal of proteins from nucleic 
acid solutions. DNA solution was mixed 1:1 with a phenol/chloroform/isoamylalcohol 
(25:24:1) mixture and centrifuged at 12000xg for 2 min at RT. Two phases were obtained in 
the tube. The upper aqueous phase was carefully removed and transferred to another tube. The 
extraction of the water phase was repeated until no impurities were visible at the phase 
interface. Traces of phenol were removed by ethanol precipitation. 
 
2.2.7 Ethanol  precipitation 
Ethanol precipitation is used for removal of phenol traces from a DNA solution after phenol-
chloroform extraction. 
DNA solution was mixed with 1/10 volume of 3M Na-acetate (pH 5.2) and 2.5 volumes of 
100% ethanol (kept at -20°C). The DNA precipitation followed overnight at -20°C or for 30 
min at -70°C. The solution was centrifuged at 14000 rpm in an Eppendorf table centrifuge for 
10 min at 4°C, supernatant removed and the pellet was washed with 100 µL of ice cold 70% 
  37  Materials and Methods 
ethanol. Precipitated DNA was dried in a vacuum centrifuge and afterwards dissolved in 
water at 65°C. Dissolved DNA was stored at -20°C. 
 
2.2.8  DNA restriction and ligation 
In this work only restriction nucleases of Type II were used. These nucleases cut DNA close 
to the recognition sequence and need no ATP for the reaction. 
3 units of enzyme per µg of DNA were used, in the appropriate buffer for the enzyme 
recommended by the manufacturer. The reaction sample was incubated 1-2 hours at the 
recommended temperature for every enzyme. 
Ligation of the DNA fragments was carried out in the presence of T4 DNA ligase overnight at 
16°C or 4 hours at RT.  
 
2.2.9  Yeast cell culture 
2.2.9.1            P. pastoris transformation 
In this work electroporation was used as a method of choice for P. pastoris cell 
transformation.  
One colony of P. pastoris strain SMD1163 was picked from the YPD plate, transferred into 5 
mL of YPD medium and incubated overnight at 30°C in the shaker with 230 rpm. 500 mL 
YPD medium was inoculated with the calculated amount of pre-culture in order to get an 
OD600 = 1.4 in a convenient amount of time, taking into account that the doubling time was 
approx 2 h. The cells were afterwards harvested by centrifugation (1500g, 5 min, 4°C), 
resuspended in 500 mL of ice cold sterile deionised H2O and centrifuged again under the 
same conditions. They were once again washed with 250 mL of H2O. After the centrifugation, 
the cells were resuspended in 20 mL of ice-cold 1 M sorbitol and repeatedly centrifuged under 
the same conditions as previously. Finally, the cells were resuspended in 1 mL of ice-cold 1 
M sorbitol, divided into 80 µL-aliquots and placed on ice. One aliquot containing 10-25 µg of 
linearized DNA (<10 µL) per transformation was mixed with 80 µL of prepared cells, the 
suspension was transferred into a pre-cooled electroporation cuvette (0.2 cm) and incubated 5 
min on ice. Following incubation, the cells were electroporated (1500 V, 25 µF, 400-500 Ω) 
and immediately after resuspended in 1 mL of cold 1 M sorbitol. The suspension was plated 
onto three MD plates and the plates incubated for two days at 30°C. After the incubation, 
clones were picked and used to screen for multiple inserts. 
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2.2.9.2   Selection of clones with multiple inserts 
The selection method is based on the presence of the kanamycin resistance gene in the 
expression vector. The resulting colonies from one transformation experiment (3 MD plates, 
see 2.2.9.1) were carefully scraped from the plates and brought together in a 13 mL-tube. The 
suspension was mixed for 10 s on the vortex, and its OD600 measured (with 1:100 dilution in 
water). Knowing that OD600 of 1 means 5 × 10
7 cells/mL, at least three different dilutions of 
the cell suspension in H2O were made, so that 1 mL contained 10
6, 10
7 and 10
8 of cells 
respectively. From the different dilutions 100 µL each were plated on the YPD-G418 plates 
with different G418 concentrations, ranging from 0.05 – 1 µg/mL. The plates were incubated 
3-4 days at 30 °C and the colonies picked for expression tests. The remaining undiluted 
suspension was diluted to 30% (w/v) with sterile glycerol, frozen in liquid nitrogen and stored 
at -80 °C. 
 
2.2.9.3   Storage of  P. pastoris clones 
Short-term storage (1-2 months) of P. pastoris clones was possible on YPD plates at 4 °C. For 
long-term storage, glycerol cultures were made. One colony was picked from the plate and 
transferred to 10 ml of YPD medium. The culture was incubated overnight at 30 °C with 
shaking at 230 rpm. The following day the cells were harvested after culture OD600 measuring 
(2000 g, 5 min, 4 °C). The pellet was resuspended in sterile 87% glycerol to final 30% 
glycerol concentration. Aliquots were made, frozen in liquid nitrogen and stored at – 80 °C. 
  
2.2.9.4   Protein production in P. pastoris 
2.2.9.4.1  Small shaking culture of P. pastoris 
One colony of the desired clone from the YPD plate was inoculated into 10 mL of BMGY 
medium in a sterile 50 mL tube. The culture was incubated overnight at 30 °C in the shaker at 
230 rpm. At an OD600 of 2-4, the cells were harvested by centrifugation at 2000 g, 5 min, at 
RT. The cells were resuspended in BMMY medium to an OD600 of 1. They were incubated in 
a 100 mL baffled flask for 24 h at 30 °C and 230 rpm. Care was taken that the culture was 
sufficiently aerated. After 12-16 h methanol was added to a final concentration of 0.5%.  
When the incubation was finished, the cells were harvested by centrifugation (2000g, 5 min, 
4°C) and either directly used for membrane preparation or frozen in liquid nitrogen and stored 
at – 80 °C. 
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2.2.9.4.2  Large-scale shaking culture of P. pastoris 
30 mL of BMGY medium in a 100 mL baffled flask was inoculated with a single colony of 
the desired clone and incubated overnight in a shaker (30°C, 230 rpm). With this pre-culture, 
2 × 1.5 L of BMGY medium in two 5 L-baffled flasks were inoculated so that the final OD600 
the following day in each was 4-6. To calculate the amount of pre-culture needed for 
inoculum, the following formula was used: 
  
   X{mL}  =  [(OD600 w / 2
t/2) × V] / OD600 m    
       O D 600 w = wanted OD 
       t   =     hours of incubation 
       V = culture volume (mL) 
       OD600 m = OD of pre-culture 
Inoculated culture was incubated overnight at 30°C in the shaker at 230 rpm. After the culture 
reached the desired OD, the cells were harvested in sterile centrifuge tubes (2000g, 10 min, 
RT). The cells were resuspended in 12 L of BMMY medium, and split into six 5L-sterile 
baffled flasks. The culture in BMMY medium was incubated 24 hours at 30°C in the shaker 
with 150 rpm. After 12-16 h, methanol was added to a final concentration of 0.5%. The cells 
were harvested after incubation (2000g, 10 min, 4°C) and the pellets resuspended in breaking 
buffer. The suspension was aliquoted in 50 mL tubes, frozen in liquid nitrogen and stored at – 
80°C. 
This was the standard procedure for al 12 L and 24 L shaking cultures. 
 
2.2.9.5          Fermentor culture of  P. pastoris 
Fermentation of P. pastoris was carried out according to the modified protocols of Invitrogen 
Inc. in a 10 L-fermentor. 
Preparation: 
The fermentor vessel was filled with 4 L of basic salt medium (see 2.1.15) and closed. 
Thermometer, methanol sensor, calibrated pH electrode, O2-sensor and sampling device were 
inserted into the vessel. Further, four tubings with closures were attached to the fermentor 
inlets. These were used during the fermentor run for adding glycerol, methanol, ammonia and 
anti-foam. The other inlets were closed and the fermentor vessel autoclaved. After cooling 
down to room temperature, the fermentor vessel was positioned onto the fermentor console 
and all the necessary connections were made. Temperature was set to 30°C.  pH value of the 
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medium was adjusted with 25% ammoniac solution to 5-6. The agitation speed was set to 600 
rpm and the aeration started (set point 10.0). Fermentor was left for 6 hours with these 
parameters, in order to polarize the O2-electrode. Afterwards the electrode was calibrated 
according to the fermentor manufacturer’s instructions (BioFlo 3000 Fermentor Handbook, 
New Brunswick Scientific). Na-hexametaphosphate solution, as well as PTM1 salts (see 
2.1.15), was slowly added to the medium. Fermentor medium was inoculated with 100 mL of 
BMGY culture so that the starting OD600 was 1.  
 
Sample collection: 
Samples of the medium were continuously taken during the fermentor run through a special 
sampling inlet. Wet weight, OD600, ligand binding and cell morphology were monitored. Wet 
weight was calculated after cells from a 2 mL suspension were pelleted (5000g, 5 min) and 
the supernatant removed. The pellet was measured on the balance to determine wet weight  
(g/L). For the ligand binding, small-scale membrane preparations were made, and 
radioactivity was measured as described in Methods. 
 
Fermentation process 
Phase I – glycerol “batch” 
During the first fermentation phase, the yeast cells consume glycerol from the medium. The 
end of this phase was easily recognized, due to the so called “oxygen spike” (the oxygen 
concentration in the medium rose to 100% in the time window of 10-15 min).  
 
Phase II – glycerol feed 
Glycerol solution (50% w/v) containing 12 mL/L PTM1 salts (see 2.1.15) was added at a rate 
of 15mL/h/liter fermentor culture. The agitation was increased to 1000 rpm and the oxygen 
control regime was changed to the “O2 cascade” (see BioFlo fermentor handbook). The 
glycerol feed was continued until a wet weight of 250-350 g/L was achieved. It was essential 
that there was no accumulation of glycerol in the medium. This was to be tested by 
disconnecting the feed for a short time. If there were no accumulated glycerol in the medium, 
an oxygen spike would appear in a very short time. 
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Phase III – methanol induction 
Protein production was induced by methanol. Since methanol is rather toxic for yeast cells in 
higher concentrations, the methanol solution (988 mL of methanol + 12 mL of PTM1 salts) 
was fed at a very slow rate. The feeding rates and induction times are described in Results. At 
the end of the induction phase, the cells were harvested by centrifugation (5000g, 20 min, 
4°C), frozen in liquid nitrogen and stored at – 80°C. 
 
2.2.9.6   Cell breaking and membrane preparation – analytical scale 
In order to determine the binding activity of the new receptor clones, membranes from 15 
mL-P. pastoris cultures were prepared. The cells in BMMY medium were pelleted at 3000g, 
4°C, for 4 min. The supernatant was removed, the cells were resuspended in 1 mL of 
Breaking buffer (50 mM Na2HPO4, 500 mM NaCl, 100 mM sucrose, 5 mM EDTA, 0.1% 
BSA) and the suspension transferred to a 2 mL Eppendorf tube. 1mM PMSF was added. 
Breaking of P. pastoris cells was carried out at 4°C in using glass beads. The beads (0.5 mm 
in diameter) were previously washed with 1M HCl, then with deionized water to neutral pH 
and dried. 1mL of the beads was added to the tube with cell suspension, mixed and vortexed 
10 min in the cold room. Meanwhile, a 5-mL Pierce plastic column with a frit was put into a 
13 mL Sarstedt tube and precooled on ice. The suspension was transferred into this column, 
together with 500 µL of breaking buffer, and centrifuged for 1 min, 2000g, 4°C. In this way 
the glass beads were separated from the suspension and retained on the column frit. The 
column was washed with 500 µL of breaking buffer, and centrifuged under the same 
conditions for a further 4 min. The supernatant in the 13 mL tubes was carefully taken out and 
transferred to an ultracentrifuge tube. Centrifugation at 100 000g, at 4°C for 30 min followed. 
The pellet obtained was resuspended in 500 µL of binding buffer (see Materials) and 
homogenized with three strokes in a hand homogenizer. Two equal aliquots were made, 
frozen in liquid N2 and stored at – 80°C until needed. 
 
2.2.9.7.  Cell breaking and membrane preparation – preparative scale 
Large amounts of yeast cells obtained from the 24 L shaker cultures or from the fermentor 
were broken mechanically, in a Dynomill  cell mill. The procedure is relatively fast and 
efficient, since after 3 passages, 80% cells were broken, as determined by visualization under 
a light microscope. 
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200-1000 g of the cells were thawed on ice overnight and resuspended in breaking buffer (see 
the previous chapter), in order to obtain a cell wet weight of 30%.  Protease inhibitor cocktail 
was added (1 mM PMSF, benzamidine, leupeptin, pepstatin A) to the cell suspension. Into the 
precooled Dynomill cell mill 500 mL of glass beads (5 mm in diameter, prewashed with 1 M 
HCl and water) were added. The cell suspension was passed 3x through the mill and the cell 
breakage rate was checked under the microscope.  The glass beads were washed with 100-300 
mL of breaking buffer (depending on the starting cell amount).  The suspension was subjected 
to low spin at 5000 rpm (JLA-8 rotor) for 20 min at 4°C, in order to remove cell debris and 
unbroken cells. The supernatant was, after addition of PMSF to a final concentration of 1mM, 
centrifuged further at 100 000xg for 45 min at 4°C. The pellets were collected, and 100 mL of 
wash&storage buffer (50 mM Tris, 1M NaCl, 10% glycerol, pH 7.4) was added to them. The 
suspension was homogenized 2x10s with the Thorax homogenizer, and then in the hand 
homogenizer. The mixture was diluted to 360-500 mL with the wash&storage buffer and 
subjected to ultracentrifugation under above described conditions, in order to wash the pellets. 
The procedure of pellet homogenization was repeated, homogenized pellets resuspended in 
200-400 mL of wash&storage buffer and flash-frozen in liquid nitrogen. Obtained membrane 
preparations were stored at - 80°C till further use. 
 
2.2.9.8    Precipitation of glycosylated α - factor signal peptide with concanavalin A 
(ConA) 
 
Half a millilitre of the solubilizate of P. pastoris cells expressing FlagHisETBBio receptor 
fusion was filtrated through a sterile 0.65 µm microfilter. Concanavalin A solution was added 
to a final concentration of 1 mg/mL and the sample incubated 1 hour at RT on a rotating 
wheel. Afterwards the sample was centrifuged for 30 min at 12 000g at 4°C. The supernatant 
was subjected to SDS electrophoresis, electroblotted and analysed with anti-Flag M2 
antibody. 
 
2.2.10   Insect  cell  culture 
2.2.10.1  Virus preparation and titre determination  
New virus was prepared from the virus stock (MPI for Biophysics, Frankfurt/M.) when at 
least 100 mL of the Sf9 cell suspension culture (cell density 5-7,5 x 10
5 cells/mL) was 
infected with the virus at MOI = 0.1. After 5-7 days of incubation in the shaker at 27°C and 
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125 rpm, the cells were pelleted by centrifugation at 6000g for 10 min, and the supernatant 
containing the virus was transferred into sterile flasks and stored at 4°C until use.  
The new virus stock was titrated before use. For this purpose, a 96-well plate with 1x10
4 
seeded cells/well was used, and each horizontal row was infected with 10 µL of a different 
sequential dilution of virus. The plate was incubated for seven days at 27°C and then the 
number of infected wells at each dilution was determined. Virus titre was calculated 
according to the End-Point dilution method (Reed and Münch, 1938), and expressed as the 
number of plaque-forming units of virus (p.f.u.)/mL of the virus stock. 
  
2.2.10.2 Protein  expression 
Ovary cells from Spodoptera frugiperda (Sf9 cells) were used for Baculovirus-mediated 
expression of the ETB receptor. The cells were cultivated in mono- and multilayers, in TNM-
FH medium supplemented with 5% FCS, 4 mM L-glutamine, 50 µg/mL gentamycin and 
10µg/L of vitamin B12. For protein production, the cells were cultivated in suspension. They 
were transferred from the cell culture flasks into Erlenbach flasks, and grown further in the 
same medium supplemented with 0.1% Pluronic. The cells were infected with the 
recombinant baculovirus at a density of at least 2.5 x 10
6 cells/mL. They were pelleted for 10 
min at 1000xg, then resuspended in fresh medium supplemented with 0.1% of Pluronic so that 
their concentration was at least 2.5 x 10
6 cells /mL, and infected with the recombinant virus. 
Multiplicity of infection was 10. Both the cells in culture flasks and in Erlenbach flasks were 
incubated at 27°C. The cells were harvested 66 h after infection with the virus. 
 
2.2.10.3  Insect cell membrane preparation 
66 hours after virus infection, the Sf9 cells were counted, and aliquots containing 6x10
5 cells 
were taken for binding assay and electrophoretic analysis. The cells were then harvested by 
centrifugation at 6000g for 10 min. Supernatant was removed and the cells resuspended in 
breaking buffer to yield 5x10
6 cells/mL. The cells were broken in a parr-bomb apparatus for 
45 min, under 500 psi N2. The lysate was spun at 1000g at 4°C for 10 min to remove cell 
debris and unbroken cells. The supernatant after the low spin was subjected to centrifugation 
at 100 000g for 1h, at 4°C. This pelleted membrane fraction was resuspended in Tris buffer 
(50 mM Tris, 1M NaCl,  10% glycerol, pH 7.4), homogenized with a hand homogenizer, 
frozen in liquid nitrogen and stored at – 80°C until further use. 
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2.2.11    Discontinuous SDS PAGE 
Analytical separation of proteins according to their molecular mass was carried out following 
the protocol of Fling and Gregerson (Fling and Gregerson, 1986).  
The samples were prepared with 4xLoading buffer (see Materials), but were not, as usual, 
subjected to heat denaturation, since this causes irreversible aggregation of GPCRs molecules. 
Electrophoresis was carried out in a vertical apparatus (hand-made at MPI for Biophysics), in 
10% separation gels, at a constant current of 20 mA per gel. The proteins in the gel were 
afterwards either stained with Coomassie Brilliant Blue or with silver nitrate, or 
electrotransferred to PVDF membranes for Western analysis. 
 
2.2.12   Blue  native  PAGE 
The electrophoresis was carried out according to the method from Schägger&von Jagow 
(Schägger and von Jagow, 1991; Schägger et al., 1994), where the proteins are not denatured 
by detergent. The migration path of the protein through the gel depends therefore not only on 
the molecular mass, but also on the shape. Polyacrylamide gels with a 6-13% gradient and 
without stacking gel (self-made) were used for the separation. Electrophoresis was carried out 
at 4°C, initially at a constant current of 10 mA and later increased to 20 mA. Afterwards, the 
gels were stained with Coomassie Brilliant blue, according to the standard protocol (see 
Protein gel staining- Coomassie staining in Methods). 15 µL of 1 mg/mL BSA solution was 
used as a marker protein. 
 
2.2.13    Electrotransfer of proteins (Western blot) 
After electrophoresis, the proteins were transferred to a PVDF membrane by electroblotting. 
The “sandwich” with 3 Whatman blotting papers (previously soaked in the 1x blotting 
buffer), protein gel, PVDF membrane (previously treated shortly with methanol and then 
soaked in blotting buffer) and 3 further Whatman blotting papers on top was made. It was 
placed to the semi-dry blotting apparatus (made at MPI for Biophysics). Protein transfer was 
carried out at constant current of 50 mA per gel for 1.5 h. Since the mixture of prestained 
molecular weight markers was used during the electrophoresis, the efficiency of the 
electrotransfer could be easily checked. 
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2.2.13.1 Anti-Flag  immunoblot 
After the transfer, the PDVF membrane was blocked 1h at RT in TBS buffer with 5% milk 
powder. The membrane was washed 2x with TBS buffer and incubated in 10 mL of the same 
buffer containing M2 anti-Flag antibody (10µg/mL) for 30 min. After washing 3x with TBS 
buffer, the 30 min long incubation with secondary antibody followed. For this purpose, AP-
conjugated goat anti-mouse IgG was used, diluted 1:1000 in TBS. The membrane was then 
washed 3x with the TBS buffer. 10 mL of AP buffer with 66µL of NBT solution and 33µL of 
BCIP solution was added to the membrane, and incubated till the purple coloured bands 
appeared. The reaction was stopped by washing the membrane with water. 
 
2.2.13.2  Detection of the ETB Bio fusion with Streptavidin-AP conjugate 
PDVF membrane with transferred proteins was incubated 1h in TBST buffer at RT. 
Afterwards, the membrane was incubated with streptavidin-AP conjugate (1:5000 dilution in 
TBST) for 30 min at RT and washed 3x with TBST buffer. Specific band detection was 
carried out as in the case of anti-Flag immunoblot. 
 
2.2.13.3 Anti-His  immunoblot 
After electrotransfer, PDVF membrane was blocked in PBS with 5% milk powder for one 
hour at RT. The membrane was then incubated with anti-His antibody (1:1000) in the same 
blocking buffer for one hour at RT. After washing 3x with PBS buffer, secondary antibody 
was added (anti-mouse IgG, alkaline-phosphatase conjugated),  in 1:1000 dilution. After 
incubation with secondary antibody for one hour at RT, the membrane was washed with PBS, 
and incubated in AP buffer for 3 min. Staining was performed with 66 µL of NBT and 33 µL 
of BCIP in 10 mL of AP buffer. The reaction was stopped by washing the membrane with 
water. 
 
2.2.14  Protein gel staining  
2.2.14.1 Coomassie  staining 
After electrophoresis, the gel was incubated 1 h in fresh Coomassie solution (see Materials). 
Afterwards, the gel was placed into the destaining solution (see Materials), together with 
Kimwipes cellulose tissues (which preferentially bind the Coomassie) and destained till the 
bands without background were clearly visible on the gel.  
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2.2.14.2 Silver  staining 
After SDS-electrophoresis, the gel was fixed for 16 min in the fixier (see Materials), and 
incubated equally long in the conditioner (see Materials). Then, the gel was washed 3x in 
water. After 20 min of incubation in silver-nitrate solution, the gel was 2x shortly washed 
with water, and then soaked in the developer until clearly visible bands appeared. The 
reaction was stopped with 50 mM EDTA solution.  
 
2.2.15    Determination of protein concentration 
For the protein concentration measurements the BCA protein assay was used (Smith et al., 
1985). This particular method has comparable sensitivity to the Bradford method, without 
being affected by the presence of detergents and lipids. The BCA assay kit from Pierce (see 
Materials) was used, according to the instruction manual. For each measurement, a new 
standard curve with BSA (1-12µg per well) was made. Absorption was measured at 562 nm in 
the spectrophotometer. 
 
2.2.16    Concentration of proteins  
2.2.16.1 Centrifugation 
Vivaspin tubes with 50 kDa-cut-off membranes from Vivascience, Lincoln, UK were used 
to concentrate the purified protein. The tubes with the protein solution were spun at 3000g at 
4°C until the desired concentration was achieved. Concentrated protein was collected from 
the upper part of the tube. 
 
2.2.16.2           TCA precipitation 
A modified protocol after Tornqvist&Belfrage (1976) was used to precipitate proteins with 
trichloroacetic acid (TCA). To 1 mL sample 25 µL of 1% Na-deoxycholate was added, mixed 
and incubated 5 min at RT. Afterwards, 1 mL of 12% cold TCA was added and the sample 
spinned 20 min at 10 000xg, 4°C. Supernatant was removed and the pellet was resuspended in 
20-100 µL of 2.5% SDS. The suspension was incubated in thermomixer at 700 upm for 10 
min, at 37°C, in order to fully dissolve the pellets. Then the 4x loading buffer was added and 
the samples loaded to SDS gel. 
 
 
  
  47  Materials and Methods 
2.2.17  Receptor solubilization from the membranes 
Endothelin B receptor was solubilized from the membranes using 1% n-dodecyl-ß-D-
maltoside. Before solubilization, the receptor was saturated with the ligand, ET-1. Membranes 
were mixed with solubilization buffer (50 mM Tris, 500 mM NaCl, 10 mM imidazole, pH 
7.4), to give final concentration of 3 mg/mL. Endothelin-1 solution in 20% DMSO (1mg/mL) 
was added in equimolar concentration as the calculated receptor concentration. The 
suspension was incubated for 2 hours with gentle mixing (magnetic mixer) at 4°C. Then, the 
detergent was added and the mixture was incubated for further 2 hours. During the incubation 
time, PMSF was added every ½ hour (final concentration 1mM), in order to prevent 
proteolytic degradation of the receptor. Following solubilization, the suspension was 
subjected to centrifugation at 100 000g, and the supernatant containing solubilized receptor 
was taken for further purification. 
 
2.2.18   Affinity  chromatography  
2.2.18.1 Imobilized  metal  affinity chromatography (IMAC) 
Crude membrane solubilizate (50-500 mL) was filtered through 0.65 µm filter and mixed with 
previously equilibrated 4-30 mL Ni-NTA matrix (equilibration buffer: 50 mM Tris, 500 mM 
NaCl, 10 mM imidazole, 0.1% LM, pH 7.4). Protease inhibitor PMSF was added in the final 
concentration of 1 mM. Batch chromatography was carried out at 4°C for two hours or 
overnight.  The mixture was packed into a column and afterwards washed with Buffer 1 (50 
mM Tris, 150 mM NaCl, 10 mM imidazole, 0.1% LM, pH 7.4). The same buffer, but with 30 
mM imidazole, was used for further washing step. Receptor protein was eluted with Buffer 3 
(50 mM Tris, 150 mM NaCl, 200 mM imidazole, 0.05% LM, pH 7.4). 
Ni-NTA matrix was regenerated with 30% CH3COOH, washed with water and stored in 30% 
ethanol. 
 
2.2.18.2  Purification on monomeric avidin matrix 
Non-specific binding sites on monomeric avidin were blocked according to the matrix 
producer instructions, and the matrix was equilibrated with Tris buffer (50 mM Tris, 150 mM 
NaCl, 10 mM EDTA, 0.05% LM, pH 7.4). The elution fraction from the Ni-NTA matrix (5-
70 mL) was mixed with 1-20 mL of monomeric avidin matrix, PMSF in DMSO in the final 
concentration of 1 mM and 50 µM DTT. Endothelin-1 peptide was added (1/5 of ET-1 
volume added before receptor solubilization - see 2.2.17). The mixture was rotated on the 
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wheel at 4°C for two hours or overnight. Following incubation, the mixture was packed into 
the column and washed with 50 mM Tris, 150 mM NaCl, 0.05% LM, pH 7.4. Protein was 
eluted from the matrix using competing free biotin added in the washing buffer in the final 
concentration of 2 mM. 
Monomeric avidin was regenerated with 0.1M glycine, pH 2.8, washed with PBS till neutral 
pH was reached and stored in PBS with 0.02% NaN3. However, this type of matrix could be 
used only up to three times, since it rapidly loses its binding capacity and has to be replaced 
by a fresh one.  
 
2.2.18.3  Purification on M1 anti-Flag antibody –bound matrix 
Eluate from Ni-NTA matrix was mixed with 1 mL of M1 antibody matrix prepared according 
to the instructions manual and equilibrated with TN buffer (50 mM Tris, 150 mM NaCl, pH = 
7.4, 0.05% LM). 10 mM CaCl2 was added. The mixture was incubated 2 h at 4ºC. After 
washing with TN buffer with 1 mM CaCl2, the protein was eluted with 10 mM Flag-peptide 
in TN buffer. 
 
2.2.18.4  Purification on streptavidin-sepharose 
Streptavidin-sepharose was made by Ms. Eva Molsberger by coupling streptavidin produced 
in E. coli, purified and refolded, to sepharose. 
10 mL of streptavidine sepharose, equilibrated with TNE buffer (50 mM Tris, 150 mM NaCl, 
10 mM EDTA, 0.05% LM, pH = 7.4), was mixed with 40 mL of eluate from Ni-NTA column 
and with DTT in final concentration of 50 µM and incubated overnight on the rolling wheel. 
Material was packed into the column and washed with TNE buffer. Receptor protein was 
eluted with TNE buffer containing 5 mM desthio-biotin. 
 
2.2.19   Analytical  gelfiltration 
Via gelfiltration (size-exclusion) chromatography, the proteins are separated according to 
their size.  
This method was used to analyse the dispersity of the purified ETB receptor. Superose 6 PV 
3.2/30 column was used, on Smart Chromatographic station from Pharmacia, Upsala, 
Sweden. After column equilibration with 50 mM Tris –buffer with 150 mM NaCl and 0.05% 
n-dodecyl-ß-D-maltoside, 50µL of the concentrated protein sample (1-2 mg/mL) was applied.  
The flow rate of 50µL/min was used, and the run was carried out at 4°C. 
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2.2.20    Radioligand binding assay 
2.2.20.1  Binding assay on membranes 
The sample of cell membrane preparation was diluted with the binding buffer (see Materials) 
to 3µg/mL of protein and incubated with radioactive [I
125] ET-1 for 1.5 hours at RT. The 
amount of radioactivity added per sample was 100 000 cpm. Total binding was always 
measured in triplicate, and non-specific binding in duplicate. For non-specific binding 
determination, 10 µM unlabeled ET-1 peptide was added. The reaction was stopped by adding 
700 µL of binding buffer and the samples were transferred to prewashed GF/C filters (blocked 
with 0.3% PEI) on the harvester. The filters were washed 3x with ice cold binding buffer, and 
then transferred to the plastic vials and put into the γ−counter for measuring. 
 
2.2.20.2  Binding assay for solubilized receptor 
Concentration of active receptor in solution was measured with the help of streptavidin-coated 
magnetic beads (Dynal, Hamburg). 20 µL of beads (10 mg/mL) were washed with ice-cold 50 
mM Tris buffer, 150 mM NaCl, 0.1% LM, pH 7.4 and resuspended in 120 µL of the same 
buffer. 10 µL of solubilized receptor was added, and incubated on ice for 5 min. Radioactive 
[I
125] ET-1 was added to the mixture in the amount of 50000 cpm/sample, and the mixture 
incubated for 1.5 hours at RT. For non-specific binding was determination, 10 µM unlabeled 
ET-1 was added. After incubation, the beads were washed carefully in magnetic rack 3 × with 
ice-cold Tris buffer, resuspended in 200 µL of the same buffer and transferred to the vials for 
counting. 
 
2.2.21   Mammalian cell culture 
For the mammalian cell culture, two types of cells were used: BHK (Baby hamster kidney 
cells), for the recombinant SF virus production, and CHO (Chinese hamster ovary) K1 cells, 
for the expression of ETB receptor. The cells were cultivated in the following medium: 
Dulbecco’s modified Eagle’s medium (DMEM) and Iscove’s 1:1, supplemented with 10% 
FKS and 4 mM L-glutamine. The cells were incubated in the NUNC incubator at 37°C, with 
5% CO2. 
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2.2.21.1  In vitro mRNA preparation 
Plasmid DNA (10-20 µg) was linearized with appropriate restriction enzyme (NruI for 
recombinant DNA with receptor, SpeI for helper DNA) in total volume of 50 µL, for 2 h at 
37°C. After running a 2µL aliquot on a 1% agarose gel to check for complete linearization, 
DNA was purified either over MicroSpin S-200 HR column (according to the instruction 
manual), or using QIAquick PCR purification kit. Purified DNA was used for the in vitro 
transcription. 
Transcription reaction: 
5 µL linearized DNA (2.5 µg) 
10 µL 5xSP6 buffer 
5 µL 10 mM CAP 
5 µL 50 mM DTT 
5 µL rNTP mix 
20 µL H2O 
2 µL Rnasin (40 U) 
5 µL SP6 RNA polymerase (100 U) 
-------------------------------------- 
50 µL 
Reaction mix was incubated at 37°C for 60 min. The result was checked by running a 2 µL 
aliquot (+ 2µL of DNA loading buffer) on a 0.8% agarose gel. 
 
2.2.21.2  Electroporation of mRNA into BHK cells 
Growth medium was aspirated from a T175 flask containing confluent BHK cells. Cells were 
washed twice with PBS, detached with 2.5 mL of trypsine/EDTA and resuspended in 30 mL 
of growth medium. Cell suspension was spun down in a 50 mL Falcon tube, at 900xg for 5 
min. Afterwards, medium was removed and cells resuspended in 30 mL PBS. The 
centrifugation was repeated as previously, and cells resuspended in the final volume of 2 mL 
PBS. 400 µL of cell suspension was transferred to 0.2 cm electroporation cuvette. Meanwhile, 
25 µL of helper mRNA reaction was added into receptor mRNA reaction, mixed and 
immediately added to the cuvette. Cells were electroporated with two pulses at RT, whereas 
time constant was every time 0.7 after each pulse. Electroporation settings: 
Capacitance extender 960 
Capacitance   25  µF 
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Resistance   & 
Voltage   1500  V 
The cells were transferred with Pasteur pipette to the T25 flask containing 10 mL of growth 
medium. Flasks were incubated 24 h at 37°C in the incubator with 5% CO2, before the virus 
was harvested. 
 
2.2.21.3  Harvesting the SF virus 
Recombinant virus was harvested 24 h after electroporation. Cell medium was transferred to 
the 10 mL syringe and filtered through a 0.22 µM filter. Solution was aliquoted and kept at –
80°C till further use. 
 
2.2.21.4  Recombinant SF virus activation 
Virus was activated by adding 500 µg of sterile α-chymotrypsine (20 mg/mL) in PBS/mL 
virus solution. The mixture was incubated at RT for 30 min. 250 µL of aprotinin in PBS (10 
mg/mL) was added to the 10 mL of virus solution in order to inhibit the enzyme. Activated 
virus was stored in 1mL aliquots at –80°C. 
 
2.2.21.5  Test infection of cells with recombinant SFV 
CHO cells were seeded into 6-well plates. When they reached 70-80% confluence, the cells 
were washed twice with 1.5 mL PBS pro well, and infected with 500 µL of virus solution. 
After 1h of incubation at 37°C, 1.5 mL of growth medium was added, and the cells were 
incubated overnight. After washing off the virus with 2x1.5 mL PBS, cells were scraped in 1 
mL of PBS, spun down for 10 min at 6000xg, pellets frozen in liquid N2 and stored at - 20°C 
till further use. 
 
2.2.21.6  Preparation of the cell lysates for electrophoresis 
Prior to electrophoresis, the cells were subjected to SDS lysis and subsequently to benzonase 
treatment to remove nucleic acids. Cells from the 6-well plate were resuspended in PBS, 
counted in Neubauer chamber and the aliquot containing 5 × 10
5 of  cells was taken. Cells 
were spun down at 1000g for 5 min and resuspended in 100 µL of benzonase buffer (50 mM 
Tris, 1.5 mM MgCl2, pH 8.0) with 1% SDS. Benzonase was added (3 enzyme units/sample) 
and the samples were incubated on ice for 20 min. Afterwards, 15 µL of 4×loading buffer was 
added, and the samples loaded to the 10% SDS PA gel. 
  52  Materials and Methods 
 
2.2.21.7  Freezing the cells 
In order to obtain frozen stocks of BHK and CHO cells for the experiments, the initial cells 
obtained from Aventis were grown in usual growth medium till 80-90% confluence. The cells 
were washed twice with PBS, detached with trypsine/EDTA and spun down for 3 min at 
300xg. Afterwards, the cells were resuspended in the growth medium containing 10% DMSO 
(for the cells from 2xT185 flasks – 5 mL). Aliquots of 0.5 mL were made in cryotubes. The 
tubes were let 30 min at RT, and then transferred to the polystyrene rack at –80°C for three 
days. The cells were finally transferred to liquid nitrogen container. 
 
 
2.2.22  2D crystallization probes 
Purified ETB receptor from P. pastoris (see 2.2.18.2) was concentrated to 1 mg/mL and mixed 
with POPC, DMPC or with E. coli polar lipids (each stock 4 mg/mL, in 1% LM) in different 
ratios, ranging from 1:1.5 to 2:1. The mixtures were incubated for 1 hour at RT with mixing, 
and then 5 mg of Bio-beads were added. The mixtures were then incubated for additional 2 
hours at RT with mixing. 1.3 µL of each sample was transferred to the grids and stained with 
uranyl-acetate. The samples were examined under electron microscope (CM12, Phillips) for 
crystalline vesicles. 
For freeze-fracture (done by Dr Winfried Haase), droplets of solution were placed on 
specimen holders of the BAF400T freeze-fracture apparatus (Balzers, Lichtenstein) and 
frozen in liquid nitrogen cooled ethane. Fractured samples were shadowed with platinum and 
carbon and the cleaned replicas viewed in an EM208S electron microscope (FEI/Philips 
company). 
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  3  Results 
 
3.1  P. pastoris expression system 
 
3.1.1  Expression vectors for ETB receptor production in P. pastoris 
In this work, all the clones used for human ETB receptor production in P. pastoris were cloned 
into expression vector pPIC9K (Invitrogen Inc., San Diego). The promotor which drives 
expression of heterologous genes in this case was the promotor for alcohol-oxidase I (AOXI) 
production.  
The receptor constructs FlagHisETBBio, FlagHisETBStab and FlagHisETBGFP were obtained 
from H. Schiller, MPI for Biophysics, and the constructs FlagHisETBStrepI, 
FlagHisETBStrepII and FlagHisETBTevBio were prepared in the course of this work.  
 
All the receptor constructs have the coding region for α-mating factor prepro-peptide of S. 
cerevisiae (shortly: α - factor) fused to the N-terminal of the receptor coding sequence. The α 
- factor is yeast secretion signal sequence and therefore should drive the expressed receptor to 
the cell membrane. The protease-cleavage site is inserted between the α-factor sequence and 
the receptor, which is recognised by P. pastoris Kex-2 protease and should provide efficient 
α-factor cleavage. The endogenous cleavable signal sequence of the ETB receptor (see 
Introduction), comprising the first 26 amino acids of the polypeptide chain, was deleted.  A 
putative N-glycosylation site of the receptor at Asn59 was removed by mutating Asn to Ala. 
Also, amino acid Arg64 was mutated to alanine, thereby deleting the protease - sensitive 
cleavage site. 
Variety of affinity tags was appended to both receptor termini in different constructs, in order 
to provide easy detection and purification of expressed receptor protein. 
Octapeptidic Flag epitope (with amino acid sequence DYKDDDDK) was introduced at the N-
terminus, for subsequent use in immunological detection and receptor purification on Flag-
M2-antibody matrix. Other tags used in this work include three short tags – a decahistidine 
tag and two kinds of nonapeptidic streptavidin-binding tags, StrepI and StrepII. The Bio-tag, 
9.7 kDa biotinylation domain of Propionibacterium shermanii transcarboxylase (Cronan, 
1990) appended to the receptor C-terminus, enabled receptor purification on monomeric 
avidin and detection with streptavidin. Fusion with the green fluorescent protein coding 
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sequence from Aequorea victoria was used to enable simple determination of the expression 
and localization of the protein inside the cell via fluorescence.  
An overview of the expression vectors described in this work is given in Fig 3.1.  
 
 
 
 
 
 
 
 
 
 
 
Fig 3.1  Overview of the expression vectors used for ETB receptor production in P. pastoris. 
AOXI = alcohol oxidase I promotor; α-factor = coding region for α-factor prepro-peptide from S. 
cerevisiae; Flag = coding sequence for Flag-peptide; His = coding sequence for 10 histidines; GFP 
= coding sequence for green fluorescent protein; Tev = cleavage site for Tev protease 
 
Tev
Strep
Hi
s1  receptor coding region  AOX1 α-factor  fl
a
Hi
s1  receptor coding region  Bio  AOX1  α-factor  fl
a
Hi
s1 Bio   receptor coding region  AOX1  α-factor 
fl
a
Hi
s1 GFP   receptor coding region  AOX1 α-factor  fl
a
 
 
 
3.1.2  Construction of the vectors FlagHisETBStrepI and FlagHisETBStrepII 
 
The Strep-tag is a nine amino-acid long tag that was developed as an affinity tool for 
purification of corresponding fusion proteins on streptavidin. In this work, StrepI 
(AWRHPQFGG) and StrepII (AWSHPQFEK) tags were used, differing in 3 amino acids and 
with KD for streptavidin binding of 37 µM and 72 µM, respectively. From the vector 
pPIC9KFlagHisETBBio, the Bio-tag fragment was removed by EcoR1/Not1  digestion. 
Hybridised oligonucleotides StrepIfor+StrepIrev or StrepIIfor+StrepIIrev were ligated with the 
digested vector, yielding a C-terminal protein fusion gene. The sequences of the resulting 
vector constructs were confirmed by DNA sequencing, and the vectors were linearized with 
SacI for transformation into P. pastoris. 
 
3.1.3  Construction of the vector FlagHisETBTevBio 
 
Because the size of the Bio-tag, 9.7 kDa biotinylation domain from P. shermanii 
transcarboxylase used in this work for purification of the ETB receptor fusion, might 
negatively influence receptor crystallization trials, the vector construct FlagHisETBTevBio 
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was prepared, with the possibility of Bio-tag removal after receptor purification. The new 
vector contains a coding region for the Tev protease cleavage site between receptor sequence 
and Bio-tag sequence. From the vector pPIC9KFlagHisETBBio, the ETB fragment was 
obtained by BamH1/EcoR1 digestion and ligated into the BamH1/EcoR1  cut vector 
pPIC9KFlagHisTevBio (Christoph Reinhart, MPI for Biophysics). The sequence of the 
resulting construct was verified by DNA sequence analysis, the DNA was linearized with 
SacI and prepared for transformation. 
 
 
3.1.4 ETB receptor production in P. pastoris 
 
3.1.4.1  Receptor expression in shaking culture 
 
It has been shown that different N-terminal and C-terminal receptor fusions influence the 
expression of GPCRs in P. pastoris (Weiss, 1998). This has been observed in the case of the 
ETB receptor as well (H. Schiller, 2000 and this work). Table 3.1 shows different vector 
constructs used in this work and the respective quantities of active receptor expressed, 
measured by radioactive [
125I]Endothelin-1 ligand binding on the membrane preparations. 
The largest amounts of the ETB receptor per liter of P. pastoris culture were obtained in this 
work with the clone pPIC9KFlagHisETBBio, which is in accordance with the previous 
findings about the positive effect of the Bio-tag on active receptor expression. These findings   
revealed a 6 - fold larger yield of the active receptor in the case of the clone containing the C-
terminally fused Bio-tag compared to the one without it (H. Schiller, 2000).  The assumption 
is that relatively long (9.7 kDa) Bio-tag stabilizes the receptor expressed in the yeast cell. 
Expression levels of P. pastoris receptor clones with C-terminally fused nonapeptides StrepI 
and StrepII were 35 pmoL/mg and 40 pmoL/mg respectively.  The receptor fusions with these 
short affinity tags lack the stabilizing effect of the Bio-tag; therefore, lower active receptor 
yields were expected. Surprisingly, the introduction of the Tev cleavage site to the 
pPIC9KFlagHisETBBio receptor construct lowered the yield of the active receptor to 25 
pmol/mg. 
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Constructs 
 
pmol of receptor/mg 
membrane protein 
µg of receptor per liter 
of shaking culture 
pPIC9KFlagHisETBBio 
 
60 ± 5  1286 
pPIC9KFlagHisETBStrepI 
 
35 ± 5  786 
pPIC9KFlagHisETBStrepII 
 
40 ± 3  824 
pPIC9KFlagHisETBTevBio 
 
25 ± 4  577 
 
TABLE  3.1  ETB expression levels in P. pastoris shaking culture. The values given are for 1L 
shaking cultures of P. pastoris. Radioligand binding assays were carried out on the isolated cell 
membranes.  
 
 
3.1.4.2   Production of the ETB receptor in P. pastoris fermentor culture 
P. pastoris is an organism extremely convenient for growing in fermentor, since this yeast 
tolerates cell densities up to 500 g /L of cell suspension. Therefore it is easily possible to grow 
large amounts of biomass (3 kg of wet weight and more) in a 10L fermentor.   
For optimal control of fermentor conditions, yeast was grown in minimal medium (see 
Materials).  Parameters such as pH, O2 level and methanol concentration were under strict 
control during the whole fermentation process.  Fermentor runs were carried out in a 10L 
fermentor, and the fermentation process was controlled using the software package 
BioFlo3000, New Brunswick Scientific. 
 
Fig 3.2    Fermentor BioFlo3000 
during fermentation process.  
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P. pastoris cells were grown on glycerol as the carbon source until they reached a wet weight 
of 350 g/L. Then the glycerol feed was stopped and O2 consumption closely monitored, until a 
significant drop in consumption was observed. The so-called “oxygen spike” is the sign that 
yeast cells in the fermentor are in starvation phase. The methanol feed was started 
immediately after, and the methanol concentration in the fermentor was kept constant (around 
0.5% (v/v)) by methanol sensor controlling.  Methanol addition induced production of the 
receptor construct. Different induction rates of methanol feed were evaluated (2 – 6 
mL/L/hour), and different induction times (10-24 h) in order to optimize receptor production 
in the fermentor. The transition from glycerol as the carbon source to methanol is a rather 
critical point in P. pastoris fermentation process. In this phase, a rise in pH value together 
with fast fluctuations in O2  consumption is observed. Therefore oxygen in surplus was 
provided in order to stabilize the transition. 
Fig 3.3 shows the time scale of receptor production and cell wet weight change during 
fermentation. The observed drop in the cell wet weight after methanol induction is the 
consequence of methanol toxicity. For this reason, the methanol concentration is kept as low 
as possible, but still high enough to provide the cells with sufficient carbon source. 
 
 
 
 
Fig 3.3   Receptor production in recombinant P. pastoris strain FlagHisETBBio in the 
fermentor. Blue line = cell mass changes with time. Red line = receptor production. 
The arrow shows start of methanol induction.  
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The cells were harvested 10-24 h after methanol induction. Receptor production was 
measured on membrane preparations of samples taken at different time points during 
induction. Maximal production rates of active receptor varied from 8-17 pmoL/mg in different 
fermentor runs. A 10 L fermentor yielded 3 kg of cells, which contained 20 - 39 mg of the 
ETB receptor. 
 
3.1.4.3   Expression of receptor fusion FlagHisETBGFP in P. pastoris 
 
Heterologous expression of receptor – GFP fusions serves as a fast and reliable method to 
verify receptor expression in the host cell, and to visually check for its localization. 
P. pastoris cells transformed with FlagHisETBGFP were observed under fluorescence 24 h 
after methanol induction. All cells showed green fluorescence, which verified the production 
of receptor-GFP fusion protein. However, it was obvious that the fusion protein was not 
localized in the cell membrane, but rather distributed inside different cell compartments. 
 
 
                           
 
A B
Fig 3.4   Expression of FlagHisETBGFP in P. pastoris.  
A) P. pastoris transformed with FlagHisETBGFP observed under light microscope B) 
the same field observed under fluorescence. Fluorescence excitation at 488 nm, with a 
510 nm filter 
 
 
3.1.5    Immunological analysis of the FlagHisETBBio receptor construct 
produced in P. pastoris 
 
In order to analyze the expression profile of the receptor construct FlagHisETBBio, 
membranes containing the receptor construct were subjected to Western blot analysis with 
anti-Flag M2 antibody. As seen in Fig 3.5, two prominent protein bands could be detected. 
  59  Results 
The lower one has the apparent Mw of 55 kDa, which correlates well with calculated 
molecular mass of the receptor construct itself. The upper one, with an apparent Mw of 74 
kDa, represents the unprocessed form of the receptor construct, where the α-factor signal 
peptide has not been cleaved by the P. pastoris Kex2 - protease. The protein band at approx 
40 kDa is a result of receptor degradation. 
 
 
                               
                                           
Mr 
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Fig 3.5  Immunological analysis
of the FlagHisETBBio receptor
construct produced in P. pastoris.
Yeast cells expressing
FlagHisETBBio were harvested
24h after methanol induction, the
membrane fraction was isolated
and 20 µg loaded on an SDS gel.
After the protein electrotransfer to
a PVDF membrane, proteins were
probed with anti-Flag M2
antibody. Lane 1: control pPIC9K
membranes, lane 2:
FlagHisETBBio membranes. 
       1             2 
 
 
3.1.6    Biotinylation of the receptor construct FlagHisETBBio in P. pastoris 
 
In the receptor construct FlagHisETBBio, the 9.7 kDa transcarboxylase domain from 
P.shermanii was fused to the C-terminus of the receptor. As a result, Lys59 of the fusion 
protein should be biotinylated in vivo. This was the necessary prerequisite for subsequent 
affinity purification of the receptor construct on monomeric avidin. 
To check whether FlagHisETBBio fusion undergoes biotinylation in P. pastoris, protein 
expression was induced with methanol according to the standard procedure (see Methods), 
membranes were prepared (see Methods) and protein biotinylation was probed with AP-
conjugated streptavidin on the blotted PVDF membrane. As a negative control, the receptor 
construct FlagHisETBStab was used. The Stab-tag is a derivative of the Bio-tag, with a Lys59 
mutated to alanine to prevent biotinylation. As seen in Fig 3.6, the receptor protein band at 
Mw of 55 kDa is clearly visible in the case of FlagHisETBBio, which verifies the biotinylation 
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of the Bio-tag in P. pastoris. However, no protein band corresponding to receptor fusion 
could be detected in the case of FlagHisETBStab. 
 
Fig 3.6 Western blot analysis of
biotinylation of receptor construct FlagHis
ETBBio in P. pastoris.  10  µg of each
membrane preparation was loaded on an SDS
gel. Proteins were blotted onto PVDF
membrane and analyzed with AP-conjugated
streptavidin. Lane 1: control membranes
pPIC9K, lane 2: membranes
FlagHisETBStab, lane 3: membranes
FlagHisETBBio. The arrow shows the
position of receptor band. 
                                            
123       
 
 
  
3.1.7    Concanavalin A precipitation of unprocessed receptor fusion protein 
 
The unprocessed form of the receptor fusion protein FlagHisETBBio, with an apparent Mw of 
74 kDa (see Fig 3.5), still contains the α-factor signal sequence. Owing to the fact that this 
signal peptide is glycosylated, precipitation with concanavalin A (ConA) was attempted. 
ConA is a lectin and binds sugars with high affinity. It is a dimer at pH 5.7, tetramer at pH 
6.8, and at higher pH values builds non-soluble aggregates and precipitates them from the 
solution. The experiment was carried out as described in Methods, at pH 7.4 and Con A was 
used at a   concentration of 1mg/mL.  
Western blot analysis shows the processed form of the receptor at the apparent Mw of 55 kDa, 
and the four distinctive bands around 74 kDa which represent the receptor fused to differently 
glycosylated  α - factor signal sequence (Fig 3.7, lane 1). After ConA precipitation, the 
correctly processed receptor band in the solubilizate is the same as in the lane 1, but only one 
band representing unprocessed form of the receptor could be detected. We assume that this is 
the receptor fused to the unglycosylated α - factor signal sequence, since it couldn’t be 
precipitated by concanavalin A. 
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Fig 3.7  Concanavalin A
precipitation – Western blot
analysis with M2 antibody. Lane
1: receptor solubilizate without
ConA, lane 2: solubilizate after
ConA precipitation 
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3.1.8         Breaking of P. pastoris cells and large-scale membrane preparation  
 
Yeast possess exceptionally sturdy cell wall, which is a problem when retrieving 
heterologously expressed, non-secreted protein from this host system.     
In this work the problem of breaking large quantities of yeast cells was solved by using a cell 
mill-DYNO-mill KDL Typ A, in which the cells were broken mechanically by passing the 
cell suspension through glass beads (0.5 mm in diameter). Cell suspension in breaking buffer 
at a wet weight of 30% was determined to be optimal for cell breakage. Under these 
conditions it was possible to break 1 kg of cells in 30 min by passing a 3L suspension 3-4 
times through the cell mill. Breaking efficiency, investigated under light microscope, was 
between 60-80%. 
After the cells were broken, they were subjected to low spin centrifugation (3000g) in order to 
remove unbroken cells and cell debris. Since the low-spin pellets still showed  [I
125] ET-1 
binding, in order to minimize losses of expressed receptor protein the pellets were passed 
once more through the cell mill and then subjected to polyethylene glycol 3000 (PEG 3000) 
precipitation.  The membranes precipitated with PEG 3000 yielded 20% of the total active 
receptor obtained in the whole membrane preparation after ultracentrifugation, as measured 
via radioligand binding assay. 
 
3.1.9  Purification of the ETB receptor 
 
Membrane preparations containing active receptor produced in P. pastoris were incubated 
with equimolar quantity of ET-1 in order to stabilize the receptor in its native conformation, 
and then the receptor was solubilized with ultra pure 1% n-dodecyl-β-D-maltoside. It was  
  62  Results 
 
previously shown (H. Schiller et al., 2001) that the solubilization efficiency of this detergent 
for the ETB receptor, under the conditions used in this work, is 60-70%.  
 
3.1.9.1    IMAC purification – identification of the chelated metal best suited for 
purification 
 
Immobilized metal affinity chromatography (IMAC) is routinely used for the purification of 
His-tagged proteins. In order to test which metal ion is the most suited one for receptor 
purification, in the terms of highest receptor purity and least aggregation, different divalent 
metal ions were coupled to Sepharose following the instructions manual. The following ions 
were tested: Co
2+, Ni
2+, Fe
3+ and Cu
2+. In parallel, two commercially available metal-coupled 
matrices were tested for comparison, Ni
2+ coupled to nitrilotriacetic acid-agarose (Ni-NTA) 
and Talon (Co
2+ coupled to Sepharose). 
Filtered receptor solubilizate, with the receptor in complex with its ligand, was loaded to the 2 
mL of each metal- bound matrix. Columns were washed first with 10 mM imidazole, then 
with 30 mM imidazole washing buffer (see Methods), and bound receptor was eluted with 
200 mM imidazole elution buffer. Washing steps and elution fractions from each column 
were analyzed on silver stained gels. After the protein concentration determination, identical 
amounts of each fraction were loaded on the gels. Since purified receptor was in complex 
with its ligand, no radioactive measurements of active receptor in the elution fraction were 
possible. 
Commercially available Ni-NTA matrix performed the best in the test; as can be seen on the 
silver gel (Fig 3.8A, lane 9), beside the protein band representing the monomeric form of the 
receptor at 55 kDa, only two impurity bands could be detected. Receptor eluted from the 
Talon matrix was also comparatively pure; however, in this eluate aggregated protein was 
visible in the upper part of the gel. (Fig 3.8B, lane 4). Interestingly enough, the “self-made” 
matrices loaded with the corresponding ions (Ni
2+ and Co
2+) performed less well than their 
commercial counterparts, since they yielded less pure receptor with more aggregates (Fig 
3.8A and Fig 3.8B, lane 7, respectively). Fe
3+-coupled sepharose eluate contained many other 
proteins beside the receptor (Fig 3.8B, lane 10), and proved the least suitable for receptor 
purification of all the metal ions tested. The Cu
2+ matrix eluate (Fig 3.8A, lane 4) yielded a 
very similar elution profile as the “self-made” Ni
2+ loaded matrix (Fig 3.8A, lane 7). 
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Fig 3.8   Different immobilized metal ions on the test for receptor affinity purification via 
His-tag – silver stained gel.  For each metal – lane 1: wash 10 mM imidazole, lane 2: wash 30 
mM imidazole, lane 3: eluate 200 mM imidazole. (*) – commercially available IMAC matrix 
 
 
3.1.9.2   Purification on Ni-NTA matrix 
 
The N-terminal decahistidine fusion (His10-tag) enabled the purification of the receptor 
FlagHisETBBio on Nickel-NTA agarose. Nitrilotriacetic acid (NTA) is a chelating group 
coupled to the polymerized agarose and charged with Ni
2+. Histidine imidazole rings from the 
His-tag provide interacting partners for immobilized metal ions. Elution of the His-tagged 
protein from the Ni-NTA matrix is possible under physiological conditions by using high 
concentrations of competing imidazole. 
Crude receptor solubilizate was incubated with Ni-NTA matrix in batch, and subsequently 
washed with increasing concentrations of imidazole (first 10 mM, then with 40 mM) in order 
to remove weakly bound proteins. Since a portion of the receptor was eluted by the 40 mM 
imidazole washing step (data not shown), in subsequent purifications the second wash was 
performed at 30 mM imidazole concentration instead. The receptor was eluted with 200 mM 
imidazole. 
In Fig 3.9 silver stained gel of the different purification steps is depicted. In addition to the 
receptor monomer at an apparent Mw of 55 kDa and the Kex2-unprocessed form at 74 kDa, 
many impurities were detected. The most prominent of these is the protein band at 
approximately 35 kDa, which represents a P. pastoris protein with strong affinity toward the 
Ni-NTA matrix, since its strong intensity was observed in all cases of receptor purification on 
Ni-NTA matrix. 
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Fig 3.9   Silver stained SDS PA
gel of receptor purification on
Ni-NTA matrix 
Lane 1: molecular weight
markers, lane 2: crude receptor
solubilizate, lane 3: wash 10 mM
imidazole, lane 4: wash 30 mM
imidazole, lane 5: elution 200
mM imidazole. Arrows mark the
positions of receptor processed
(55 kDa) and unprocessed form
(74 kDa) 
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3.1.9.3   Purification on monomeric avidin matrix 
 
Avidin is a tetrameric glycoprotein with a molecular mass of 67 kDa. Its affinity towards 
biotin is the strongest non-covalent interaction described so far. This interaction can be 
interrupted only under harsh conditions, which makes avidin unsuitable for affinity 
purification of native proteins. Monomeric avidin proved a better candidate for this purpose, 
having much lower KD for biotin (10
-7).  
The receptor fusion protein FlagHisETBBio binds to the monomeric avidin via its biotinylated 
Bio-tag fused to the receptor C-terminus.  
Monomeric avidin affinity matrix was employed as a second step in receptor purification, 
after the Ni-NTA matrix. It is not suitable for use as a first column for receptor purification 
since it is expensive and has rather low binding capacity for membrane proteins in detergent. 
Purification was carried out in batch, as described in the Methods section. Receptor was 
eluted with 2mM free biotin.  
The elution fraction was concentrated in a concentrator cell with a 50 kDa cut-off to 1-2 
mg/mL and its dispersion state analyzed by gel chromatography on Superose 6 resin (Fig 3.10 
B). Concentrated protein was also analyzed by silver staining (Fig 3.10A). 
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Fig 3.10  Purification of FlagHisETBBio on Ni-NTA and monomeric avidin matrix. 
(A) Silver stained gel – lane 1: molecular weight markers, lane 2: Ni-NTA eluate, lane 
3: monomeric avidin eluate  (B) Superose 6 gel filtration profile of purified 
receptor 
 
 
On the silver stained gel, a prominent band of receptor monomer at an apparent Mw of 55 
kDa could be seen. Only one more band, a low intensity protein band at approx 100 kDa 
could be detected. The retention profile from the Superose 6 column shows, in addition to the 
receptor monomeric peak (retention volume 1.61 mL), aggregated receptor with a smaller 
retention volume. 
Since it was not possible to follow receptor purification by radioligand binding (the receptor 
was purified in complex with its ligand), estimation of the yield of purified receptor was made 
based on receptor quantity in the starting membranes and protein concentration determination 
in the concentrated sample of purified receptor. By this method, it was estimated that the 
receptor yield after purification was 32% of the starting amount. 
 
3.1.9.4   Purification of the receptor on M1 anti-Flag antibody matrix 
 
Receptor fusion protein FlagHisETBBio contains an N-terminally fused Flag octapeptide, 
which permitted receptor purification on an M1 anti-Flag antibody-bound matrix as a second 
purification step.  Every step in the purification procedure was performed in the presence of 
Ca
2+ ions, since M1 antibody binds the Flag peptide only when calcium is present in the 
buffer. Elution under mild conditions with competing free FLAG-peptide was employed, so 
as not to perturb receptor’s native conformation.  
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The crude solubilizate was first purified on a Ni-NTA column as already described, and then 
mixed with 1 mL of antibody matrix and 10 mM CaCl2. Chromatography was performed in 
batch at 4ºC. After a washing step, the receptor was eluted with 100 mM FLAG peptide.  
The eluate was concentrated to 1.36 mg/mL and analysed on a Superose 6 gel filtration 
column and by silver staining. 
As depicted in Fig 3.11B, the protein elution profile from Superose 6 shows a dominant 
elution peak at 0.91 mL, which most probably represents aggregated receptor. The small peak 
with absorption maximum at 2.04 mL represents the free FLAG peptide present in the elution 
fraction with the receptor protein. 
Eluate analysis on the silver stained gel (Fig 3.11A) shows a monomeric receptor band at 55 
kDa, the Kex2-unprocessed form of the receptor at 74 kDa and massive aggregates at higher 
Mw. The protein band at 35 kDa is most probably a fragment of proteolysed receptor, 
commonly observed in receptor preparations from yeast. 
                                                                                                                                                                               
         
-0,02
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
0,16
0,18
0123
   
4
volume (mL)
A
U
2
8
0
Mr (kDa) 
97 
66 
45 
29 
   1          2         3 
A B
 
Fig 3.11  FlagHisETBBio purification on Ni-NTA and M1 anti-Flag matrix.  
A) Silver-stained SDS gel  Lane 1: molecular weight markers, lane 2: eluate from Ni-
NTA matrix, lane 3: eluate from M1 anti-Flag matrix. B) Gel filtration elution profile 
(Superose 6) of M1 anti-Flag concentrated eluate 
 
 
3.1.9.5  Purification via Strep-tag 
 
Purification of the receptor on a streptavidin matrix was evaluated as a possible alternative to 
the more expensive monomeric avidin matrix. For this purpose, the FlagHisETBStrepI clone 
was used. The StrepI tag nonapeptide binds to streptavidin with an affinity of 34 µM, in the 
  67  Results 
same binding pocket as biotin. Therefore it is possible to employ a rather gentle elution with a 
biotin derivative, which competes for the same binding place on streptavidin. The receptor 
fusion protein was first purified on Ni-NTA matrix as already described, and then incubated 
with 10 mL of streptavidin-sepharose. After 2 hours of incubation and the washing step, the 
receptor was eluted with 5 mM desthio-biotin. The eluate was analysed by gel filtration and 
the silver staining. The gel filtration elution profile of the receptor purified in this way showed 
massive receptor aggregation (Fig 3.12), very similar in the profile and in the extent with 
receptor aggregates after purification on the M1 matrix (Fig 3.11). Aggregates are also 
observed in the eluate analyzed on silver stained gel, where they occur in the form of a broad 
smear at high molecular weight. The monomeric form of the receptor occurs on the gel with 
an apparent Mw of 45 kDa (the arrow). This purification technique was abandoned because of 
the extensive receptor aggregation. 
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Fig 3.12  (A) Eluate analysis by silver staining (B) Gel filtration analysis of the 
receptor purified on streptavidin matrix (Superose 6).  
  Lane 1: molecular weight markers, lane 2: streptavidin eluate 
 
 
 
3.1.10   Investigating receptor aggregation 
 
 
3.1.10.1  The influence of the oxidation state and differently processed forms of the 
receptor on aggregation 
 
In order to investigate whether receptor aggregation is caused by receptor oxidation, non-
reductive electrophoresis was run in parallel with reductive. The former contained no β-
mercaptoethanol in the loading buffer. As could be seen on the silver stained gel of samples of 
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purified receptor with or without β-mercaptoethanol in the sample buffer (Fig 3.13), no 
significant difference in the receptor migration profile was observed. Particularly significant 
is the absence of a difference in the high molecular weight area on the gel. There, additional 
receptor bands would be expected to appear under non-reducing conditions due to the 
intermolecular disulfide bond formation.  Since it is not the case, it can be concluded that 
receptor oxidation is probably not the cause of receptor aggregation.   
 
  Mr (kDa) 
              
Fig 3.13  Silver-stained protein bands
after non-reductive and
reductive electrophoresis.  
Lane 1: marker proteins, lane
2: protein sample run without
β-mercaptoethanol in loading
buffer, lane 3: protein sample
run with β-mercaptoethanol in
loading buffer. 2.5 µg of
protein loaded on 10% SDS gel 
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3.1.10.2  The effect of glycerol on receptor aggregation 
 
Since it is commonly accepted that small amounts of glycerol have a positive influence on 
native proteins in solution, all buffers in the initial purification trials contained 10% glycerol. 
Gel filtration analysis of the monomeric avidin eluate from the initial purification trials 
showed several different absorption peaks at 280 nm, which points to the receptor 
heterogeneity with aggregation. When the glycerol was omitted from the buffers during 
receptor purification, subsequent gel filtration analysis of the purified receptor showed the 
predominant monomeric form of the receptor, although the aggregates were still present (Fig 
3.14B). 
On the other hand, when receptor purification was carried out with 30% glycerol in the 
buffers, gel filtration elution profile of the purified protein showed massive aggregation of the 
receptor (Fig 3.14A). 
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Fig 3.14  The effect of glycerol on receptor aggregation.  
Gel filtration analysis (Superose 6) of the purified receptor with (A) 30% glycerol, (B) 
0% glycerol. The arrow shows monomeric form of the receptor  
 
 
 
 
3.1.10.3  The effect of buffer additives on receptor aggregation 
 
In order to address the problem of receptor aggregation, it has been tried with addition of 
many different substances during FlagHisETBBio receptor fusion purification on Ni-NTA and 
monomeric avidin affinity matrices. 
Short-chain lipids (1,2-dicaproyl-sn-glycero-3-phosphocholine, 0.2%), physical chaperones 
ectoine and hydroxyectoine (1% each), cholesterol-hemisuccinate (0.5%) and DMSO (2%) 
were all tested in the hope of reducing the aggregation of solubilized receptor. The additives 
were present in the buffer in the given concentrations during the entire purification procedure, 
and were added before receptor solubilization with n-dodecyl-β-D-maltoside. Superimposed 
Superose 6 gel filtration elution profiles of purified receptor from those trials are depicted in 
Fig 3.15. 
None of the additives helped in obtaining a fully homogeneous purified receptor form. 
 
 
  70  Results 
             
-0,01
0
0,01
0,02
0,03
0,04
0,05
0,06
0,07
0,08
0,09
00 , 511 , 522 , 533 , 5
 
 
Fig 3.15   Superose 6 gel filtration analysis of receptor purified with different buffer additives. 
Blue line – Cholesterol-hemisuccinate; green – DMSO; red – ectoines. The arrow 
shows the position of receptor monomeric form, with the retention volume of 1.61 mL 
 
 
3.1.10.4 Blue  native  electrophoresis of the purified receptor 
 
Native electrophoresis was used to further investigate the homogeneity and oligomerization 
state of the purified receptor sample. The advantage of this method is that the protein retains 
its native state, since electrophoresis is carried out in the absence of SDS detergent.  The blue 
native electrophoresis technique developed by Schägger&von Jagow (Schägger and von 
Jagow, 1991) especially for membrane proteins was used. In this system, 6-amino-caproic 
acid provides the ions – gel current carriers, and Coomassie Brilliant Blue binds to the 
proteins giving them a uniformly negative charge.  A sample of the receptor fusion protein 
purified by Ni-NTA and monomeric avidin affinity chromatography (see 3.1.9.3) was 
subjected to electrophoresis. BSA was used as a marker protein, since it exists as monomer 
(66 kDa), dimer (132 kDa) and trimer (198 kDa) under native conditions. The gel was stained 
with Coomassie Blue following the standard procedure (see Methods) to visualise the protein 
bands. The most prominent receptor band is found at Mw ~130 kDa on the gel, indicating the 
predominant existence of dimerized receptor in the sample. Much weaker band at ~180 kDa 
could be detected, indicating the trimeric form of the receptor. Since it was possible to 
visually follow the protein band separation and migration during the run because of the nature 
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of the running buffer (it contained Coomassie Brilliant Blue), it should be noted that no 
monomeric form of the receptor was detected during electrophoresis. 
 
      
Mr (kDa) 
Fig. 3.16    Blue native electrophoresis of ETB 
receptor fusion protein. 
Lane 1: BSA, 15 µg, lane 2: purified 
receptor protein, 20 µg. Arrow shows the 
position of receptor dimer band  198 
132 
66 
  12
 
 
 
 
3.2  Expression of the ETB receptor in insect cells 
 
3.2.1  Time scale of receptor production in Baculovirus expression system 
 
A suspension culture of Spodoptera frugiperda (Sf9) cells was infected with recombinant 
virus pVlMelHisETBBio (titre 1.39 × 10
8 p.f.u/mL) at a MOI = 10. After 0, 24, 36, 42, 48, 54, 
60, 66 and 72 h cell aliquots were taken, cells pelleted by centrifugation and the pellets stored 
at - 80°C. The membrane preparations were subsequently subjected to radioligand binding 
measurements in order to establish the level of receptor production. 
The results show that receptor production in Sf9 cells starts between 24 h and 36 h after virus 
infection, and reaches its peak approximately 66 h after infection. 
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Fig 3.17  Dependence of receptor production levels in Sf9 cells on the time after infection.  
Mean values with standard deviation are shown, out of three independent radioligand 
binding measurements with [I
125] endothelin-1 on membrane preparations 
 
 
 
 
3.2.2  Expression of ETBGFP fusion in insect cells 
  
Expression of receptor-GFP fusion represents a fast and easy way to visualize receptor 
expression in the host system. For this purpose, pVLMelFlagHisETBGFP recombinant 
baculovirus (H. Reiländer, MPI for Biophysics) was used. Adherent Sf9 cells were infected 
with recombinant virus and observed 72 hours post infection by fluorescence microscopy.  
As depicted in Fig 3.18, nearly all the cells showed fluorescence. Different cell fluorescence 
intensities can be explained by different number of recombinant viruses which infected each 
cell, since the multiplicity of infection was >1. Most of the expressed protein was observed in 
the cell membrane. Diffuse fluorescence was observed in the cell cytoplasm as well, which 
means that part of expressed receptor fusion stayed intracellularly. 
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Fig 3.18  Sf9 cells expressing ETB-GFP fusion. 
a) Sf9 cells infected with pVlMelFlagHisETBGFP observed under white light with 
phase contrast b) the same cells observed under fluorescent light. Fluorescence 
excitation at 488 nm, with the filter at 510 nm 
 
 
3.2.3  Immunological analysis of ETB receptor produced in insect cells 
 
Sf9 cells infected with pVLMelFlagHisETBBio recombinant baculovirus were harvested 66 h 
after infection, an aliquot was taken for Western blot analysis and from the rest membranes 
were prepared according to the procedure described in Methods. Benzonase-treated cell 
extract (see Methods) from approx 50 000 Sf9 cells was loaded on a 10% SDS gel, together 
with 20 µg of membrane preparation, and after electrophoretic separation, transferred to 
PVDF membrane. Immunological analysis was performed with anti-Flag M2 antibody in 
order to confirm receptor expression and with streptavidin-AP conjugate to confirm 
biotinylation of the receptor construct. 
A single band at an apparent Mw of 55 kDa representing monomeric receptor was detected in 
the cell extract of Sf9 cells infected with the pVLMelFlagHisETBBio recombinant virus (Fig 
3.19, lane 2). Control uninfected Sf9 cells show no immunostaining at the same apparent Mw. 
Western blot analysis with streptavidin shows the protein band in the cell extract of infected 
Sf9 cells at the same apparent Mw of 55 kDa (Fig. 3.20). Since the streptavidin-AP conjugate 
recognizes only receptor with a biotinylated Bio-tag, it could be concluded that the receptor 
fusion protein undergoes biotinylation in Sf9 cells. 
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Fig 3.19  Immunological analysis of  FlagHisETBBio
produced in Sf9 cells. 
  Western blot analysis with anti-Flag M2
antibody. Lane 1: Sf9 cells, lane 2: Sf9 cells
infected with pVlMelFlagHisETBBio, lane 3:
membrane preparation from Sf9 infected with
pVlMelFlagHisETBBio. The arrow shows the
ETB receptor band position. 
 
          1       2       3 
 
 
                                
Mr (kDa) 
Fig 3.20  Biotinylation of FlagHisETBBio
produced in Sf9 cells. Western
blot analysis with streptavidin –
AP conjugate. Lane 1: Sf9 cells,
lane 2: Sf9 cells infected  with
pVlMelFlagHisETBBio, lane 3:
membrane preparation from Sf9
infected with
pVlMelFlagHisETBBio 
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3.2.4  Solubilization of the ETB receptor from insect cell membranes  
Different detergents were tested in order to find one that yielded the highest amount of active 
solubilized receptor. Non-ionic, mild detergents – maltosides with different carboxydrate-
chain lengths of and Fos-cholines were used at the final concentration of 1% to solubilize 
membranes of Sf9 cells expressing FlagHisETBBio (only the detergent Fos-16 was used at the 
final concentration of 0.1%, because of its low CMC, and the digitonin/cholate mixture was 
1.25%/0.3%). Membranes were incubated with detergents for 2 h at 4°C, the suspension 
centrifuged at 100 000g for 1h and the supernatant containing solubilized receptor was taken 
for further analysis. The amount of solubilized active receptor was determined based on [I
125] 
endothelin-1 binding to the receptor bound to streptavidin-coated beads. Radioligand binding 
assay showed that n-dodecyl-β-D-maltoside (LM), lauryl-sucrose (LS) and digitonine/cholate 
solubilized the comparatively largest amounts of active receptor (Fig 3.21). These detergents 
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yielded nearly equal amounts of solubilized active receptor, whereas the Fos16 detergent was 
less efficient. The detergents Fos 12 and Fos 14 solubilized negligible amounts of active 
receptor, as well as octyl-glycoside. The corresponding solubilized receptor bands for these 
detergents on the Western blot are less intensive (Fig 3.22, lanes 3, 8 and 9), so it can be 
concluded that they are generally less efficient in receptor solubilization. Western blot 
analysis with anti-Flag M2 antibody shows a single band of solubilized receptor at an 
apparent Mw of 55 kDa in each detergent solubilizate. 
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Fig 3.21  Efficacy of different detergents in the ETB receptor solubilization from the 
membranes of Sf9 cells. The amount of active receptor in the solubilizate was 
determined by [I
125] ET-1 binding on the receptor bound to the streptavidin beads. 
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Fig 3.22  Western blot analysis of solubilized ETB in different detergents. 
Lane 1: FlagHisETBBio membrane preparation, lane 2: empty, lanes 3-10: Octyl-
glucoside, LS, LM, UM, Digitonin/Cholate, Fos12, Fos14 and Fos16 solubilizates 
respectively. 
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3.2.5             Purification of ETB receptor produced in insect cells 
 
Membranes of the Sf9 cells producing FlagHisETBBio were solubilized with 1% n-dodecyl-β-
D-maltoside, which was chosen as one of the three best performing detergents tested (see 
previous chapter) and the solubilized receptor subjected to two-step affinity chromatography. 
The receptor was again purified in complex with its ligand, ET-1, to render it more stable 
during the purification process. First, receptor was purified on Ni-NTA matrix. After washing 
steps with 10 mM and 30 mM imidazole, bound receptor protein was eluted with 200 mM 
imidazole. Monomeric avidin was used as the second affinity matrix. The Ni-NTA eluate was 
incubated in batch with this matrix and during the washing step a low molecular impurity 
copurified on the Ni-NTA matrix could be removed (Fig 3.23A, lane 6, 7). Following this 
method, receptor was purified to high homogeneity. A single receptor band was obtained 
when the eluate was analysed on a silver gel (Fig 3.23A, lane 8, 9).  
The aggregation state of the receptor in the eluate was analyzed via Superose 6 gel filtration. 
The elution profile depicted in Fig 3.23B shows a single symmetric peak with an elution 
volume of 1.61 mL, which we assume is a monomeric form of the ETB receptor within a 
detergent micelle.  
Since the receptor was purified in complex with its ligand ET-1, the radioligand activity 
measurements on the purified receptor were not possible. 
 
 
 
Fig 3.23  Purification of
FlagHisETBBio from insect cells.
A) Different steps during purification
analyzed on a silver stained gel –
lane 1: molecular weight markers;
lane 2: solubilizate; lane 3: wash 10
mM imidazole; lane 4: wash 30 mM
imidazole; lane 5: elution 200 mM
imidazole; lane 6,7: wash monomeric
avidin; lane 8: eluate monomeric
avidin; lane 9: eluate from (7)
concentrated 40-fold with 50 kDa
cut-off membrane.   
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3.3       Expression of ETB in mammalian cells 
  
3.3.1  Construction of the expression vectors pSFV3CAPETBHis and 
pSFV3CAPETBGFP 
 
In this work, two different vector constructs for ETB expression in mammalian cells were 
prepared: pSFV3CAPETBHis and pSFV3CAPETBGFP. The expression vector pSFV3CAP 
was provided by Dr. Christoph Reinhart, MPI for Biophysics.  The ETBHis fragment was 
obtained by BamH1/EcoR1 digestion from the pPIC9KFlagETBHis expression vector, gel 
purified and ligated into the BamH1/EcoR1 digested pSFV3CAP vector. The ETBGFP 
fragment was obtained by BamH1/Not1 digestion from the vector pPIC9KFlagETBGFP, gel 
purified and ligated with the pSFV3CAP DNA. The sequence of the resulting expression 
vector constructs was verified by dideoxy - DNA sequencing. 
 
 
 
 
 
 
 
 
Fig 3.24   Vector constructs for ETB expression in mammalian cells.  CAP  =  capsid                 
protein coding sequence; MCS = multiple cloning site; His = decahistidine fusion; GFP = 
green fluorescent protein from Aequorea victoria 
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3.3.2    Expression of ETBGFP fusion protein in BHK cells 
 
In order to visually investigate receptor expression in adherent BHK cells, the cells were 
infected with pSFV3CAPETBGFP recombinant SFV. The cells were infected at 70% 
confluence and observed under the fluorescence at different time points after infection. The 
fluorescence in the cells could be observed already 8 hours after virus infection, but the 
strongest intensity was observed 24 h after infection. Seventy-two hours after infection, no 
fluorescence could be detected in BHK cells. In the Fig 3.25B, diffuse fluorescence 
throughout the cell could be seen, indicating that the expressed receptor is found in different 
cell compartments. 
 
 
                                                B A
 
Fig 3.25  Expression of  ETBGFP fusion protein in BHK cells.  a) BHK cells expressing 
ETBGFP fusion 24 h after infection, observed under white light with phase contrast b) 
same section of BHK cells expressing ETBGFP fusion, observed under fluorescence. 
Fluorescence excitation at 488 nm with 510 nm filter 
 
 
3.3.3  Expression of ETB receptor in CHO cells  
 
Adherent CHO cells were infected with recombinant virus pSFV3CAPETBHis and harvested 
24 h after infection. Western blot analysis with anti-His monoclonal antibody showed three 
bands in the CHO cells infected with the virus. The protein band at an apparent Mw of 80 kDa 
can be explained as the receptor fusion with CAP protein, which has a Mw of 30 kDa. The 
protein band at 50 kDa corresponds to the full-length ETB receptor. Somewhat lower band at 
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approx 40 kDa may correspond to shortened ETB receptor, which underwent proteolytical 
cleavage. 
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Fig 3.26 Western blot analysis of His-
tagged ETB receptor expressed
in CHO cells. Lane 1: CHO
cells; lane 2:  CHO cells infected
with pSFV3CAPETBHis, 8 µL;
lane 3: the same as (2), 4 µL. 
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The maximal expression rate achieved in CHO cells was 7 pmoL/mg protein, as measured by 
radioligand binding assay with [I
125] ET-1. 
 
3.4  2D crystallization trials 
 
The ETB receptor (construct FlagHisETBBio) produced in P. pastoris was purified on Ni-
NTA and monomeric avidin matrix (see 3.1.9.3) and used in 2D crystallization trials in final 
concentration of 1.0 mg/mL. Crystallization set-up probes contained the protein mixed with 
different phospholipids (DMPC, POPC, E. coli polar lipid mixture) in 1% LM, as described in 
Methods chapter. Detergent was slowly removed by adsorption with Bio-beads, and 
negatively stained probes were investigated by electron microscopy.  
In all the probes vesicles could be detected, ranging in size from 50-700 nm. The largest 
vesicles, some of which were multilayered, were found in the probes with DMPC (Fig 3.27) 
and POPC. In the sample with E. coli polar lipids, 4-5 fold smaller vesicles were found 
compared to the other two lipids. However, none of them looked crystalline. Between the 
vesicles, protein precipitates were frequently found. The question was whether the protein 
was incorporated into the vesicles at all, which was hard to judge on negatively stained 
vesicles. 
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Fig 3.27  Electron micrographs of phospholipid vesicles in crystallization set-ups.  
A) vesicles in protein sample with DMPC  B) multilayered vesicle in the DMPC 
sample. The protein concentration was 1 mg/mL, and the protein:lipid ratio 1.3:1 
 
 
 
Fig 3.28 Freeze-fracture electron 
micrographs of ETB vesicles 
reconstituted with different lipids. 
(A) POPC, (B) DMPC  
(C) E. coli polar lipids. Bars 100 
nm. 
Arrows show receptor molecules 
incorporated into vesicles. 
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In order to verify the presence of the receptor in lipid vesicles, freeze-fracture experiments 
were performed. Freeze-fracture of the vesicles (kindly done by Dr. W. Haase) showed 
protein incorporation in all the samples where vesicles were found (Fig 3.28). Especially large 
number of multilayered lipid vesicles with a high density of inserted protein was found in the 
sample with DMPC lipids. A characteristic example of such a vesicle is presented in the Fig 
3.28B. 
No crystalline surfaces within any of the vesicles were found. 
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4 Discussion 
 
The first crystal structures of membrane proteins were obtained with proteins isolated from 
naturally abundant sources, and recombinant proteins still represent minority of the membrane 
proteins that have been crystallized to date. In the case of soluble proteins, over 90% have 
been crystallized using recombinant protein, which is in contrast to the 21 recombinant of 50 
total structures for membrane proteins (Loll, 2003). Only three mammalian membrane 
proteins to date have had crystal structures determined using recombinant protein: 
prostaglandin H2 synthase-2 (COX-2), produced in insect cells (Barnett et al., 1994; 
Kurumbail et al., 1996), monoamine-oxidase B, produced in yeast (Binda et al., 2002) and 
fatty acid amide hydrolase, produced in bacteria (Bracey et al., 2002). All three proteins are 
monotopic membrane proteins and therefore have little hydrophobic surface. It should also be 
noted that the only GPCR crystallized to date, bovine rhodopsin, was obtained from the 
natural source, from bovine retina where it is found in large amounts. These statistics reflect 
the fact that active recombinant membrane proteins are difficult to obtain.  
It is not surprising that heterologous production of membrane proteins poses big challenges. 
Unlike their cytoplasmic counterparts, membrane proteins have a longer way to the fully 
functional form. Once their synthesis begins, the complicated secretory machinery is engaged 
in order to achieve proper targeting and insertion into to the membrane. The major part of 
protein synthesis yield in many cells are cytoplasmic proteins; such cells have no sufficient 
capacity to handle large amounts of newly synthesized membrane proteins. Therefore, when 
produced in a heterologous system, membrane proteins can saturate the secretory pathway of 
the cell, leading to protein aggregation inside different cell compartments. 
Therefore, the choice of expression system is a crucial step towards obtaining large amounts 
of receptor in its active form. Devising a successful strategy for its subsequent purification is 
nonetheless important.  
 
4.1  Comparison of receptor production in different hosts 
 
The endothelin B receptor was produced during the course of this work in three different 
expression hosts: yeast P. pastoris, Sf9 insect cells and mammalian CHO cells. 
The highest receptor yield was obtained using yeast as a host; the best expressing clone, 
FlagHisETBBio, with an expression of 60 pmol/mg of membrane protein, yielded 1.2 mg of 
receptor/L shaking culture. By fermentation of the same P. pastoris clone in the 10L 
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fermentor, it was possible to obtain 3 kg of yeast cells, which contained 20-39 mg of the 
receptor.  
The quantity of active ETB receptor produced in Sf9 insect cells with a maximal expression of 
30 pmol/mg protein was 0.7 mg receptor/L cell culture. This value is in accordance with 
previously reported data obtained from insect cells (Doi et al., 1997). In this report, wild-type 
ETB receptor was produced at 100 pmol [I
125] ET-1 binding activity/mg of membrane protein, 
whereas the deletion of the first 36 receptor amino acids lowered the expression to 30 
pmol/mg.  Compared to receptor production in yeast, the receptor yield from the insect cells is 
lower and the system handling is more time-consuming, but the choice of this host can be 
rewarding in terms of obtaining homogeneous receptor preparation after purification. 
The expression of active ETB receptor of 7 pmoL/mg in adherent CHO cells is lower than 
expected, taking into account that the vector construct containing the capsid protein sequence 
(pSFV3CAP) was used for receptor production. The capsid gene contains a translation-
enhancement signal on its 5’ end, which reportedly resulted in 5-fold higher expression of 
human neurokinin 1 receptor compared to a construct lacking the capsid protein (Lundstrom 
et al., 2001).  
CHO cells are certainly financially the most challenging host for receptor production, and 
with an expression level for the ETB receptor of 7 pmol/mg achieved in this work, can not be 
recommended for large scale receptor production. 
It should be mentioned that the most often used host for protein production in general, E. coli, 
was not evaluated as a host for ETB production in this work, but earlier trials of receptor 
production in E. coli yielded 41 binding-active receptors/cell (Haendler et al., 1993). This 
amount of the active receptor obtained is too low for E. coli to be seriously considered as a 
competitive candidate for large-scale heterologous expression of the ETB receptor. 
 
4.2  Production of the ETB receptor in P. pastoris 
 
The ETB receptor constructs used for production in yeast have various affinity tags fused to 
the receptor in order to allow its easy detection and purification.  
The amount of active receptor obtained from P. pastoris is strongly dependent on the vector 
construct used for transformation. It was previously reported that the highest yields of the ETB 
receptor were obtained with clones containing the Bio-tag fusion (H. Schiller et al., 2000), 
which was verified during the course of this work. The same report showed that, on the other 
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hand, the introduction of a His-tag at the receptor C-terminus dramatically lowers the yield of 
active receptor. Therefore, all the vector constructs used in this work had N-terminally fused 
decahistidine tag. The highest amount of active receptor in this work - 60 pmoL/mg 
membrane protein - was obtained for the FlagHisETBBio receptor fusion. Previously reported 
expression level for the same clone was 40 pmoL/mg (Schiller et al., 2000). The clones 
FlagHisETBStrepI and FlagHisETBStrepII, prepared in order to enable receptor purification on 
streptavidin, had expression levels between 35-40 pmol/mg membrane protein. Here the 
stabilizing effect of the relatively large Bio-tag on the expressed receptor was abolished by 
having much shorter, nonapeptidic Strep-tags fused to the receptor C-terminus and therefore 
the yield of active receptor was lower. 
Unexpectedly, the introduction of the 8 amino acid-long Tev protease cleavage site to the 
receptor clone FlagHisETBBio, yielding the clone FlagHisETBTevBio, lowered the yield of  
active receptor to 25 pmol/mg. 
 
4.3  Large scale expression of ETB in P. pastoris yeast cells 
 
After testing several ETB receptor constructs, the receptor fusion FlagHisETBBio was chosen 
for obtaining large amounts of protein for purification. The reasons were the high expression 
rate in P. pastoris of 60 pmol/mg of membrane protein, and the presence of three different 
affinity tags, Flag- and His10 on the N-terminus and Bio-tag on the C-teminus, which were 
used for subsequent receptor detection and purification. 
The highest expression rates of this receptor clone were achieved in shaking culture, where 
upon methanol induction up to 1.2 mg of receptor per liter of culture were obtained.  
Fermentor culture of the same receptor clone, however, had a lower expression yield. It has 
been attempted, by applying different methanol induction rates and different induction times, 
to increase the overall yield of the receptor in the fermentor, but the maximal expression 
achieved was 17 pmol/mg of membrane protein. This is three-fold lower than expression of 
the same clone in the shaking culture. Still, in total, the 10L-fermentor yielded 39 mg of 
receptor protein. Since larger amounts of receptor were obtained by fermentation of a same 
receptor clone (H. Shiller, personal communication), fermentation of FlagHisETBBio needs 
further optimization in order to achieve the receptor production level as in the shaking culture. 
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4.4  Protein localization after heterologous expression  
 
Expression of the receptor fusion with GFP in P. pastoris and BHK cells clearly showed that 
a large portion of expressed receptor could be found intracelullarly.  This is in accordance 
with previous findings on ETB and other GPCRs produced in the same host. Although all the 
vector constructs for ETB receptor production in P. pastoris have the N-terminally fused α-
factor signal sequence from S. cerevisiae, which naturally leads to protein secretion and drives  
protein transport to the plasma membrane (Romanos, 1995), only a small fraction of the 
receptor produced was actually found in the yeast plasma membrane. One reason could be 
that the overproduced receptor is a burden for the secretion machinery in the yeast cell, and 
only small amount of produced protein is transported to the membrane. 
Immunogold electron microscopy revealed that ETB receptor produced in P. pastoris was 
mainly located intracelullarly (Schiller et al., 2000). Interestingly enough, this report showed 
that, in the case of expression of the receptor fusion FlagETBGFP, the receptor was found in 
bulky vesicular structures consisting of stacked membranes. When the localization of the 
same receptor fusion lacking a glycosylation site was analysed, these structures were not 
found. Very similar observations were made for other GPCRs expressed in the same host 
(Reiländer, 2000).  
From the experiments with the ETB-GFP fusion expressed in BHK cells, it seems that the 
majority of the receptor expressed is localized in the cell interior and not on the cell plasma 
membrane. This is also the case with the β2 adrenergic receptor (Darui Huo, personal 
communication) and with the human neurokinin 1 receptor (Lundstrom et al., 2001), both 
expressed in the same host. It has been previously reported that during the course of transient 
expression of human neurokinin 1 receptor in mammalian cells after infection with 
recombinant Semliki Forest virus, 80% of the expressed receptor was found intracellularly, 
but was active (Lundstrom et al., 2001). 
The endothelin B receptor expressed in Sf9 insect cells infected with pVlMelFlagHisETBGFP 
recombinant baculovirus shows localization in the plasma membrane of the insect cell, 
although part of the expressed receptor could still be found in the cell interior. It seems that 
the signal sequence of the insect protein mellitine, N-terminally fused to the receptor 
construct, is efficient in driving receptor transport to the plasma membrane of Sf9 cells. 
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4.5  Biotinylation of FlagHisETBBio receptor fusion  
 
Biotinylation in vivo on the transcarboxylase domain of P. shermanii (Cronan, 1990), C-
terminally fused to the receptor, represents an artificially introduced receptor post-
translational modification. Since the amino acid sequences that lead to in vivo biotinylation of 
the protein are highly conserved in different organisms (Samols et al., 1988), it occurs also in 
P. pastoris and in insect cells.  
Quantitative measurements of the biotinylation rate in P. pastoris for the β2  adrenergic 
receptor fusion β2ARBio showed 95 ± 5% biotinylation efficiency (Reinhart, 2000). 
Biotinylation efficiency in insect cells was quantitatively investigated in the case of Bio-
“tagged” β2 adrenergic receptor (50 ± 10%) (Reiländer, 2000) and serotonine 5HT5A receptor, 
where  biotinylation rates between 25-50% were measured (Röhrig, 1997). 
Biotinylation of ETB receptor fusions from both P. pastoris and insect cells could be easily 
confirmed by immunoblot analysis with streptavidin (see Results). This biotinylated “tag” 
was used in this work for the purification of receptor fusion protein on avidin matrix, its 
immunological detection during different purification steps and for receptor radioligand 
binding assays on streptavidin-coated beads.  
 
4.6  Large scale membrane preparation from P. pastoris cells 
 
With the introduction of the cell mill Dynomill KDL A, it was possible to mechanically break 
large amounts of yeast cells in a relatively short time (1 kg wet weight of cells were broken in 
30 min with 60-80% efficiency). Additionally, with repeated passage of the low-spin pellets 
through the cell mill and subsequent membrane precipitation with PEG 3000, it was possible 
to recover additional membranes, which contained up to 20% of the total active receptor.  
However, the bottleneck in membrane preparation lies in the subsequent high spin 
centrifugation step at 100 000g, which is performed in order to pellet the yeast cell 
membranes. Large volumes of supernatant obtained after removal of unbroken cells and cell 
debris had to be centrifuged in a Beckman Ti45 rotor, which has a maximum capacity of 410 
mL per run. With 2.5 L of low spin-supernatant to be centrifuged, membranes to be pelleted 
and then pelleted again after washing, this remains the most time-consuming step in the 
course of large scale membrane preparation.  
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4.7  Partial Kex-2 protease processing of the receptor produced in P. pastoris 
 
Western blot analysis of the receptor produced in yeast showed the presence of  two receptor 
forms in the membranes: correctly processed receptor with a Mw of 55 kDa, and the receptor 
form still containing the α-factor signal sequence with a Mw of 74 kDa. This indicates that 
the  α-factor cleavage by the yeast Kex-2 protease was not complete and yielded a 
heterogeneous receptor preparation. An attempt was made to remove the unprocessed portion 
of the receptor with concanavalin A, based on the fact that the α-factor signal sequence is 
glycosylated. However, it was not possible to completely remove the unprocessed receptor 
from the solubilizate, since a portion of unprocessed receptor fused to the non-glycosylated α-
factor could not be precipitated with Con A.  
 
4.8  The exceptional characteristics of ETB-ligand complex  in comparison to other 
GPCRs 
 
The endothelin B receptor binds its ligand, ET-1, with a KD 7 pM, which is an exceptionally 
tight  (Takasuka et al., 1991) and the complex reportedly survives even in 1% SDS at low 
temperature. The ligand-receptor complex is stable in the cell for at least 2 hours, although it 
reaches the lysosome within 30 min after internalization. A full explanation for this 
phenomenon has not yet been found. It can be attributed in part to the role of ETB as a 
clearance vehicle for ET-1 from circulation, taking into account that endothelin’s lethal dose 
is 15 µg/kg body weight and that its levels in human plasma must therefore be strictly 
controlled. 
Since binding of the ligand renders the receptor more stable and less prone to aggregation 
(Doi et al., 1997, H. Schiller et al., 2001), receptor in this work was always purified in 
complex with ET-1. However, the disadvantage of this approach was that radioactive ligand 
binding measurements of the active receptor quantities during different purification steps were 
not possible.  
 
4.9  Protein aggregation  
 
The tendency of the ETB receptor produced in yeast to aggregate represented the most serious 
obstacle in obtaining the homogeneous protein preparation required for crystallization 
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attempts, and considerable efforts were made during this work to find a solution for this 
problem. 
There are many possible causes of receptor aggregation, and a number of them were 
addressed in the course of this work. 
GPCRs are aggregation prone proteins since they have large hydrophobic domains. With 
soluble proteins, it is quite common that aggregation is mediated by non-specific interaction 
of hydrophobic surface areas between monomers. The presence of detergent and the relatively 
low ionic strength of the buffers used in this work should minimize this kind of interaction. 
Aggregates can also be formed as a result of receptor oxidation, since receptors possess free 
cysteines (the ETB receptor has 16 in total; one in extracellular loop, six in the transmembrane 
domain and nine in intracellular loops) in its polypeptide chain. When this is the case, such 
aggregates can be easily observed on polyacrylamide gels under non-reducing vs. reducing 
conditions.  Since the same protein band pattern was obtained in both cases, it can be 
concluded that receptor aggregation is not due to the formation of intermolecular disulfide 
bridges between receptor molecules. During purification, 50 µM DTT was used as a reducing 
agent. There is a possibility that this reduces the naturally occurring disulfide bridge in the 
receptor (A. Oksche, personal communication), but no difference in the receptor aggregation 
pattern was observed when purification was performed in the presence and absence of DTT. 
Yet another cause of receptor aggregation could be the  Ni
2+ ions released from the Ni-NTA 
affinity matrix during purification. These ions could concurrently bind several His-tags fused 
to receptor molecules and in this way cause receptor aggregation. For this reason, in this work 
10 mM EDTA was added to every protein eluate from Ni-NTA matrix. 
Because it is commonly accepted that glycerol has a positive effect in stabilizing proteins in 
solution, initial receptor solubilization and purification were always performed in the presence 
of 10% glycerol. However, after aggregation problem was observed, many of the receptor 
purification parameters were changed. Omitting glycerol from the buffers resulted in an 
increased level of the monomeric receptor form and in fewer receptor aggregates. Conversely, 
when receptor purification was carried out in the presence of 30% glycerol, the receptor was 
mainly found in its aggregated form (see Results section). It seems that glycerol promotes 
aggregation of the ETB receptor, and it was subsequently omitted from further receptor 
purification protocols. 
Delipidation of the receptor protein could be yet another cause of its aggregation, since lipids 
have stabilizing effect on membrane proteins. Since it has been shown that during purification 
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of the ETB receptor solubilized with n-decyl-ß-D-maltoside, the receptor undergoes total 
delipidation (Doi et al., 1997), it seemed a reasonable idea to try to provide external lipids. 
Purification in the presence of short-chain lipids - 0.2% 1,2-dicaproyl-sn-glycero-3-
phosphocholine was attempted, hoping that it could have protective role against receptor 
aggregation, since lipids bind to exposed hydrophobic receptor domains and prevent their 
interaction. Unfortunately, short-chain lipids didn’t give any positive results in stabilizing the 
receptor in its native form. Addition of 1% cholesterol-hemisuccinate (a water-soluble 
derivative of cholesterol) during receptor purification gave the same result. 
Yeast membranes have a different lipid content, qualitatively and quantitatively, than those of 
mammalian cells. The major difference is that yeast membranes contain ergosterol, which 
gives them the necessary rigidity. In mammalian cells, cholesterol has this role. It has been 
tried to change yeast membrane lipid composition-ergosterol was replaced with cholesterol, in 
order to create more natural membrane surrounding for the overexpressed receptor. This 
approach resulted in even more receptor aggregation than usual. 
In addition, both ectoins and hydroxyectoins were evaluated as buffer additives in the hope of 
stabilizing the receptor monomer form. These compounds are physical chaperones present in 
extreme halophilic bacteria. Ectoins are amphoteric, water-binding organic molecules that 
form large hydration shells and reportedly stabilize proteins and nucleic acids in 
extremophiles in their native state (Galinski, 1993). Therefore, they were added to all   
solutions used during receptor purification, to 1% w/v, but no profound effect on preventing 
receptor aggregation was observed. 
 
Further experiments in this direction are required, in order to identify a substance or a mixture 
of substances which can stabilize the receptor in its monomeric form or aid in resolving the 
receptor aggregates once they form. 
 
4.10 Receptor  dimers? 
 
With regard to the large amount of recently published data on GPCR homo- and 
heterooligomerization (see Introduction), the question of ETB receptor oligomers emerged.  
In this work, blue native electrophoresis of monomeric avidine eluate showed, apart from a 
portion of receptor aggregates which couldn’t enter the gel, a prominent band with an 
apparent molecular mass corresponding to receptor dimer. However, further experiments are 
needed to obtain a definite proof of this finding, since the native electrophoresis could 
  90  Discussion 
produce artefacts in certain cases. Additionally, the use of non-membrane proteins as 
molecular weight markers for native electrophoresis of membrane proteins has to be 
validated. 
It should be noted that it was not possible to obtain a reliable calibration curve for membrane 
proteins on a Superose 6 gel filtration column, where the precise relation of the Mw of a 
solubilized protein and its retention volume can be established. Whereas such a calibration 
curve for soluble proteins is easily obtained, it seems that for solubilized membrane proteins 
the size of the detergent micelle they are in is different for different proteins. So, the retention 
time on a gel filtration column depends for a membrane protein not only on the molecular 
weight, but also on the size of the detergent micelle. Therefore this method could not be 
reliably used for dimerization analysis of the ETB receptor. 
To date, there is no published data on endogenous homodimerization of the ETB receptor, and 
it is believed that the functionally active form of the receptor is monomer. However, one 
report on ETA-ETB functional heterodimerization (Harada et al., 2002) hints that new findings 
on ETB receptor dimerization are to be expected. 
 
4.11  Affinity purification of the endothelin B receptor 
 
Affinity purification is the most commonly used purification method for GPCR proteins, and 
the most efficient one. There are two different approaches: affinity purification of the receptor 
based on receptor-ligand interaction, or based on affinity tags fused to the receptor protein. 
Using the first approach, so-called ligand affinity chromatography, Doi and co-workers 
purified the ETB receptor in complex with biotinylated endothelin on avidine (Doi et al., 
1997). Because of the costly endothelin peptide, this kind of purification is not suitable for  
large-scale. 
Two-step affinity purification based on affinity tags fused to the receptor protein is a more 
suitable approach for obtaining milligram quantities of pure protein. In this work, a 
combination of IMAC and monomeric avidin chromatography proved most appropriate for 
purifying large amounts of receptor protein.  
Immobilized metal affinity chromatography is recommended as a first step in receptor 
purification,  because of its robustness and low cost. Large amounts of membrane solubilizate 
can be loaded on this kind of matrix without a problem and the protein is eluted under 
physiological conditions with an excess of imidazole, which can be subsequently removed by 
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dialysis, if needed. In this work,  Ni
2+ as a metal ligand (compared to Co
2+, Fe
3+ and Cu
2+ 
ions), performed best in receptor purification.  
Monomeric avidin was used for the second step in receptor purification. Avidin is a 
homotetramer, which binds biotin with very high affinity (Kd = 10
-14). This interaction is, in 
addition to that between streptavidin and biotin, one of the strongest known non-covalent  
interactions. This makes it an unsuitable candidate for protein affinity purification, since very 
harsh conditions have to be employed in order to disrupt the interaction and elute the protein. 
Avidin dissociation into monomers leads to a conformation change in each of the subunits, 
which lowers their affinity toward biotin (Kd = 10
-7), and makes it possible to employ mild 
elution conditions with a solution containing free biotin. In this work, a C-terminally fused 
Bio-tag containing in vivo biotinylated lysine enabled purification of receptor fusions on a 
monomeric avidin matrix. This purification step yielded receptor at greater than 95% purity  
as judged from silver stained gels. However, this is an expensive matrix, with a relatively low 
binding capacity and which can’t be efficiently regenerated after its use for membrane protein 
purification in the presence of mild detergents.  
Unfortunately, all attempts to find an alternative for the use of monomeric avidin 
(streptavidin, M1 anti-Flag antibody matrix) were not fruitful, mainly because of massive 
receptor aggregation that occurred during purification on these affinity matrices.  
 
4.12  Double receptor band after heterologous expression in CHO cells 
 
Immunoblot analysis of the ETBHis10  receptor produced in CHO cells revealed a major 
double band with an apparent molecular weight between 40-50 kDa and one protein band of 
80 kDa. 
The minor band at 80 kDa most probably represents full-length receptor protein fused to 
capsid protein (Mw 30 kDa). Although the capsid protein undergoes autocatalytic cleavage 
upon expression of the fusion with receptor, it could be that the self-cleavage is not complete. 
A very similar result was obtained with the β2 adrenergic receptor when produced using the 
same expression vector (Darui Huo, personal communication).  
The major double band seen by Western blot analysis of His-tagged protein reveals the 
existence of two receptor species, one with a molecular weight of 50 kDa and one of 
approximately 40 kDa. The 50-kDa receptor band represents the full-length receptor, whereas 
the presence of the 40-kDa receptor band may indicate N-terminal proteolysis by proteases. 
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Although the protease cleavage site (R64 ↓ S65) in the receptor sequence was removed by 
mutating Arg64 to alanine, it is possible that the receptor still undergoes N-terminal 
degradation. This is in accordance with previously reported findings that this modification 
does not prevent receptor proteolysis in HEK293 cells and that the cleavage appeared to be 
independent of the receptor sequence (Grantcharova et al., 2002). The physiological role of 
N-terminal receptor cleavage is as yet unclear. However, it has been reported that this 
proteolysis does not destroy receptor function or overall structure, as it is the case with the 
vasopressin V2 (Kojro and Fahrenholz, 1995) or the β2 adrenergic receptor (Jockers et al., 
1999). 
Since no double band was observed at 80 kDa, it is possible that the fusion with capsid 
protein protects the receptor from proteolytic cleavage at its N-terminus. 
 
The radioligand binding on the membranes of CHO cells infected with pSFV3CAPETBHis 
recombinant virus showed 7 pmol of active receptor binding/mg of membrane protein. The 
possible reason for such a low yield of active receptor in the CHO cells could be that the 
majority of produced receptor is in its inactive state, incorrectly folded, because of saturated 
protein processing and translocation machinery.  
 
4.13  2D crystallization trials 
 
The initial step in 2D protein crystallization is the reconstitution of the protein into lipid 
vesicles (Rigaud et al, 1995).  For this to be accomplished, detergent removal is a 
prerequisite. Dialysis is the most often used method for detergent removal. However, because 
of its low critical micellar concentration (CMC),  this method was not particularly suitable for 
n-dodecyl-β-D-maltoside used in this work for receptor solubilization. For this reason, 
removal of detergent by adsorption to Bio-beads was the method of choice. A disadvantage of 
this procedure for fast detergent removal is that the precise control of detergent removal or 
detergent concentration measurement is not possible. Therefore special effort was made to 
find a balance between the amount of the Bio-Beads used and the length of time they were 
present in the solution. 
For the lipid reconstitution of the purified ETB receptor, vesicles were prepared using the 
polar E. coli lipids, DMPC and POPC. Although the freeze-fracture sections of the vesicles 
clearly showed protein incorporation, none of the vesicles showed crystalline pattern when 
investigated by electron microscopy. 
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Another approach to receptor 2D crystallization was crystallization of the receptor fusion 
FlagHisETBBio with fluorinated Ni
2+ lipids. These lipids have already been successfully used 
for the 2D crystallization of membrane proteins (Levy et al., 1999). Fluorinated Ni
2+ lipids 
build a lipid layer on the surface of 2D crystallization probe, and are protected from detergent 
solubilization by fluorination. The receptor is “fished out” and bound to Ni
2+ via its His-tag, 
and the detergent removed by the Bio-Beads. Although the initial attempts with this method 
were made, no lipid reconstitution of the ETB receptor could be detected.  
 
4.14 Outlook 
 
The yeast P. pastoris was demonstrated to be a reliable expression system for the ETB 
receptor, yielding large amounts of active protein. Milligram quantities of purified receptor 
were obtained after affinity purification combining Ni-NTA and monomeric avidine matrices. 
However, since the receptor aggregation problem was not completely solved, further efforts in 
this direction are needed. 
Receptor production in insect cells may be more promising, since in this case the receptor was 
obtained in a homogeneous monomeric form after purification. However, this expression 
system is more costly and time-consuming than receptor production in yeast, and the overall 
receptor yield per liter of culture is smaller.  
Receptor expression in mammalian cells needs to be improved. Although the N-terminal 
proteolysis of the receptor does not influence its activity, the heterogeneity of the sample (the 
existence of two receptor forms) poses a potential problem for structure studies. Nevertheless, 
transient expression of receptor in mammalian cells gives interesting possibilities for 
functional studies, since the receptor is produced in a native environment. 
It would be interesting to address the question of receptor oligomerization by means of FRET 
(fluorescence resonance energy transfer) or BRET (bioluminescence resonance energy 
transfer) experiments, which have proven informative in the case of some other GPCRs (for 
review see Bouvier, 2002) and which could ultimately provide interesting insights concerning 
the endogenously active form and in vivo dimerization of the ETB receptor.  
To date, there is no test system for in vivo G-protein coupling of GPCRs produced in P. 
pastoris. This yeast has a very low amount of endogenously expressed G-proteins, and a very 
limited number of different G-proteins. One possibility would be to genetically modify a P. 
pastoris strain in order to produce either the promiscuous Galpha16 protein or Gq and Gi, the 
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main coupling Gα−protein partners for ETB, together with Gβγ subunits. In this way it may be 
possible to directly test the signalling activity of the receptor in yeast spheroplasts.  
This work has demonstrated that the amounts of receptor expressed in yeast and insect cells 
and the yield of active receptor, which can be isolated by purification, represent a good basis 
for starting 3D and continuing 2D crystallization trials. 
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I Abbreviations 
 
AP   -  alkaline  phosphatase 
ATP   -  adenosine-triphosphate 
cAMP   -  cyclic adenosine-monophosphate 
cDNA   -  complementary deoxyribonucleic acid   
BHK    -  baby hamster kidney 
BSA    -  bovine serum albumin 
CAP   -  capsid  protein 
CHO    -  chinese hamster ovary 
Cpm   -  counts  per  minute 
DMSO   -  dimethyl-sulfoxide 
DNA   -  deoxyribonucleic  acid 
DTT   -  dithiothreitol 
EDTA   -  ethylenediaminetetraacetic acid 
FCS    -  fetal calf serum 
GDP   -  guanine  diphosphate   
GPCR   -   G-protein coupled receptor 
GTP   -  guanine-triphosphate 
IgG   -  immunoglobulin  G 
LB   -  Luria-Bertani   
LBD   -  ligand-binding  domain 
LD   -  lethal  dose 
NK   -  neurokinine 
NMDA -  N-methyl-D-aspartate 
OD   -  optical  density 
PA   -  polyacrylamide 
PAGE   -  polyacrylamide gel electrophoresis 
PBS    -  phosphate buffered saline 
PEG   -  polyethylene-glycol 
PMSF   -  phenylmethylsulfonylfluoride 
RNA   -  ribonucleic  acid 
RT   -  room  temperature 
SDS    -  sodium dodecyl sulphate 
2D   -  two-dimensional 
3D   -  three-dimensional 
TBS   -  Tris-buffered  saline 
TCA   -  trichloroacetic  acid 
TGF    -  tumor growing factor 
TMH   -  transmembrane  helix 
 
 
II  Amino-acid sequences of affinity tags used in this work 
 
        
Flag-tag      DYKDDDDK 
His10-tag      HHHHHHHHHH 
  110StrepI-tag      AWRHPQFGG 
StrepII-tag      AWSHPQFEK 
Bio-tag    GGGTGGAPAPAAGGAGAGKAGEGEIPAPLAGTV
     SKILVKEGDTVKAGQTVLVLEAMKMETEINAPTD 
GKVEKVLVKERDAVQGGQGLIKIG 
 
 
III  cDNA and amino-acid sequence of the human ETB receptor (SRS-EMBL-EBI 
database, AC L06623; SWISS-PROT P24530) 
 
 
1    ATGCAGCCGC CTCCAAGTCT GTGCGGACGC GCCCTGGTTG CGCTGGTTCT 
         M  Q  P   P  P  S  L   C  G  R   A  L  V   A  L  V  L     
 
51    TGCCTGCGGC CTGTCGCGGA TCTGGGGAGA GGAGAGAGGC TTCCCGCCCG 
            A  C  G   L  S  R   I  W  G  E   E  R  G   F  P  P   
    
101    ACAGGGCCAC TCCGCTTTTG CAAACCGCAG AGATAATGAC GCCACCCACT 
        D  R  A  T   P  L  L   Q  T  A   E  I  M  T   P  P  T      
 
151     AAGACCTTAT GGCCCAAGGG TTCCAACGCC AGTCTGGCGC GGTCGTTGGC 
          K  T  L   W  P  K  G   S  N  A   S  L  A   R  S  L  A  
    
201     ACCTGCGGAG GTGCCTAAAG GAGACAGGAC GGCAGGATCT CCGCCACGCA 
              P  A  E   V  P  K   G  D  R  T   A  G  S   P  P  R      
 
251     CCATCTCCCC TCCCCCGTGC CAAGGACCCA TCGAGATCAA GGAGACTTTC 
          T  I  S  P   P  P  C   Q  G  P   I  E  I  K   E  T  F      
 
301     AAATACATCA ACACGGTTGT GTCCTGCCTT GTGTTCGTGC TGGGGATCAT 
         K  Y  I   N  T  V  V   S  C  L   V  F  V   L  G  I  I     
 
351     CGGGAACTCC ACACTTCTGA GAATTATCTA CAAGAACAAG TGCATGCGAA 
           G  N  S   T  L  L   R  I  I  Y   K  N  K   C  M  R      
 
401     ACGGTCCCAA TATCTTGATC GCCAGCTTGG CTCTGGGAGA CCTGCTGCAC 
          N  G  P  N   I  L  I   A  S  L   A  L  G  D   L  L  H      
 
451     ATCGTCATTG ACATCCCTAT CAATGTCTAC AAGCTGCTGG CAGAGGACTG 
         I  V  I   D  I  P  I   N  V  Y   K  L  L   A  E  D  W     
 
501     GCCATTTGGA GCTGAGATGT GTAAGCTGGT GCCTTTCATA CAGAAAGCCT 
           P  F  G   A  E  M   C  K  L  V   P  F  I   Q  K  A      
 
551     CCGTGGGAAT CACTGTGCTG AGTCTATGTG CTCTGAGTAT TGACAGATAT 
          S  V  G  I   T  V  L   S  L  C   A  L  S  I   D  R  Y      
 
601     CGAGCTGTTG CTTCTTGGAG TAGAATTAAA GGAATTGGGG TTCCAAAATG 
         R  A  V   A  S  W  S   R  I  K   G  I  G   V  P  K  W     
 
651     GACAGCAGTA GAAATTGTTT TGATTTGGGT GGTCTCTGTG GTTCTGGCTG 
           T  A  V   E  I  V   L  I  W  V   V  S  V   V  L  A      
 
701     TCCCTGAAGC CATAGGTTTT GATATAATTA CGATGGACTA CAAAGGAAGT 
          V  P  E  A   I  G  F   D  I  I   T  M  D  Y   K  G  S      
 
  111751     TATCTGCGAA TCTGCTTGCT TCATCCCGTT CAGAAGACAG CTTTCATGCA 
         Y  L  R   I  C  L  L   H  P  V   Q  K  T   A  F  M  Q     
 
801     GTTTTACAAG ACAGCAAAAG ATTGGTGGCT GTTCAGTTTC TATTTCTGCT 
           F  Y  K   T  A  K   D  W  W  L   F  S  F   Y  F  C      
 
851     TGCCATTGGC CATCACTGCA TTTTTTTATA CACTAATGAC CTGTGAAATG 
          L  P  L  A   I  T  A   F  F  Y   T  L  M  T   C  E  M      
 
901     TTGAGAAAGA AAAGTGGCAT GCAGATTGCT TTAAATGATC ACCTAAAGCA 
         L  R  K   K  S  G  M   Q  I  A   L  N  D   H  L  K  Q     
 
951     GAGACGGGAA GTGGCCAAAA CCGTCTTTTG CCTGGTCCTT GTCTTTGCCC 
           R  R  E   V  A  K   T  V  F  C   L  V  L   V  F  A      
 
1001    TCTGCTGGCT TCCCCTTCAC CTCAGCAGGA TTCTGAAGCT CACTCTTTAT 
          L  C  W  L   P  L  H   L  S  R   I  L  K  L   T  L  Y      
 
1051    AATCAGAATG ATCCCAATAG ATGTGAACTT TTGAGCTTTC TGTTGGTATT 
         N  Q  N   D  P  N  R   C  E  L   L  S  F   L  L  V  L     
 
1101    GGACTATATT GGTATCAACA TGGCTTCACT GAATTCCTGC ATTAACCCAA 
           D  Y  I   G  I  N   M  A  S  L   N  S  C   I  N  P      
 
1151    TTGCTCTGTA TTTGGTGAGC AAAAGATTCA AAAACTGCTT TAAGTCATGC 
          I  A  L  Y   L  V  S   K  R  F   K  N  C  F   K  S  C      
 
1201    TTATGCTGCT GGTGCCAGTC ATTTGAAGAA AAACAGTCCT TGGAGGAAAA 
         L  C  C   W  C  Q  S   F  E  E   K  Q  S   L  E  E  K     
 
1251    GCAGTCGTGC TTAAAGTTCA AAGCTAATGA TCACGGATAT GACAACTTCC 
           Q  S  C   L  K  F   K  A  N  D   H  G  Y   D  N  F      
 
1301    GTTCCAGTAA TAAATACAGC TCATCTTGA                        
          R  S  S  N   K  Y  S   S  S  *     
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  114 Zusammenfassung  
 
 
Zellen besitzen die Fähigkeit auf verschiedene Signale aus ihrer Umgebung adäquat 
zu reagieren und dadurch mit anderen Zellen zu kommunizieren. Die Signale werden 
durch eine große Anzahl unterschiedlicher Signalstoffe - von Proteinen und kleinen 
Peptiden über Aminosäuren, Nukleotide, Steroide und Fettsäurederivate bis hinzu 
gelösten Gasmolekülen wie Stickstoffmonoxid - vermittelt. Einige dieser Moleküle, die 
klein und hydrophob sind, dringen in die Zielzelle ein, indem sie durch die 
Lipiddoppelschicht der Zellmembrane diffundieren. Sie aktivieren intrazelluläre 
Rezeptoren, die dann direkt auf der Ebene der Gentranskription wirken. Die meisten 
extrazellulären Signalstoffe aber sind hydrophil und folglich nicht in der Lage in die 
Zelle durch Diffusion einzudringen. Stattdessen binden diese Botenstoffe an der 
extrazellulären Seite von integralen Membranproteinen, Membranrezeptoren 
genannt, und lösen eine Signalkaskade im Inneren der Zelle aus.  
 
Die größte und pharmakologisch interessanteste Gruppe der Membranrezeptoren ist 
die Superfamilie der G-Protein-gekoppelten Rezeptoren (G-protein coupled receptors 
(GPCR)). GPCR-kodierende Gene machen zwischen ein und fünf Prozent des 
Wirbeltiergenoms aus (ca. 1% des menschlichen Genoms). Da G-Protein gekoppelte 
Rezeptoren der Angriffspunkt vieler Medikamente sind, sind sie von großer 
Bedeutung für die pharmazeutische Industrie. GPCRs besitzen sieben die Membran 
durchspannende Helices (sieben transmembrane Helices) und sind für die 
Übertragung des Signals aus der extrazellulären Umgebung in die Zelle 
verantwortlich. Die Signalkaskade hat folgenden Ablauf: der Ligand, der auf der 
extrazellulären Seite bindet, löst eine Konformationänderung des Rezeptors aus. 
Wenn der Ligand ein Agonist ist, wird diese Konformationsänderung auf die 
intrazelluläre Seite des Rezeptors übertragen, wodurch hetrotrimere G-Protein an ihn 
binden. Die Bindung an dem Rezeptor verursacht die Dissoziation des G-
Proteinkomplexes in α und βγ Untereinheiten, welche daraufhin verschiedenen 
Effektorsysteme aktivieren. 
 
Um den Mechanismus der Signalübertragung zu verstehen und neue Angriffspunkte 
für diese medizinisch wichtige Proteinfamilie entwickeln zu können („structure-based 
drug design“), ist die dreidimensionale (3D) Strukturaufklärung notwendige 
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Rinder-Retina mit einer Auflösung von  2,8 Å gelöst worden. Die Struktur anderen 
GPCRs wurde daraufhin am Computer simuliert. 
Der Endothelin-B-Rezeptor (ETB), dessen Überproduktion, Solubilisierung und 
Reinigung das Thema dieser Arbeit ist, gehört zur Gruppe A („Rhodopsin ähnlich“) 
der G-Protein gekoppelte Rezeptoren. Der ETB  Rezeptor  wird vom Peptidligand 
Endothelin aktiviert, wodurch die Signalkaskade gestartet wird, die letztendlich zur 
Erweiterung der Blutgefäße führt. Der ETB Rezeptor ist außergewöhnlich, weil er 
seinen Ligand fast irreversibel bindet. Deswegen und hinsichtlich seines 
pharmakologischen Wertes ist seine 3D-Struktur äußerst interessant. 
 
Die Voraussetzung für die Aufklärung der 3D-Struktur von G-Protein gekoppelten 
Rezeptoren ist die Verfügbarkeit großer Mengen homogenen Proteins. Die 
benötigten Proteinmengen könnten nicht aus natürlichen Quellen gewonnen werden, 
da das Protein nur in geringen Konzentrationen im Gewebe exprimiert wird. 
Zusätzliche Probleme liefert die Heterogenität der Rezeptoren, da mit Hilfe von 
molekularbiologischen und pharmakologischen Techniken verschiedene Subtypen im 
Gewebe identifiziert werden konnten. Sie sind während der Reinigung sehr schwer 
oder überhaupt nicht voneinander zu trennen. Um ausreichende Mengen an dem 
gewünschten Rezeptor homogen zu produzieren, greift man auf geeignete 
Expressionssysteme für Heterologen Rezeptorproduktion zurück.  
Jedoch ist die Wahl eines geeigneten Expressionssystems nicht einfach. Es ist zu 
bedenken, dass es sich bei  G-Protein gekoppelten Rezeptoren um Membran-
proteine handelt, deren hydrophobe Domänen in die Membran inseriert und richtig 
gefaltet werden müssen. Zusätzlich können sie eine Vielzahl von komplizierten post-
translationalen Modifikationen tragen. 
Die Eignung verschiedener Expressionssysteme – Hefe, Insekten- und Säugerzellen 
- zur funktioneller Überproduktion von ETB Rezeptor wurde in dieser Arbeit getestet 
und anschließend die entsprechenden Solubilisierungs- und Reinigungsmethoden, 
die eine homogene Rezeptorpräparation zum Ziele hatte. 
Hefen sind einzellige Eukaryonten, die den Vorteil eines eukaryontischen Wirtes, der 
die notwendigen post-translationalen Modifikationen an humanen Proteinen 
durchführen, mit sich bringt. Zusätzlich stellen sie ein kostengünstiges, leicht 
skalierbares  Expressionssystem für die Produktion großer Proteinmengen dar. In 
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verwendet. Sie ist eine methylotrophe Hefe, die fähig ist als einzige Kohlenstoffquelle 
Methanol zu nutzen. Die Hauptvorteile von P. pastoris sind wie folgt: 1) ist es möglich 
mit dem starken Genpromotor der Alkoholoxidase 1 (AOX1) ein hohes Niveau der 
heterologen Proteinexpression zu erzielen (30% des gesamten Zellproteins) 2) lässt 
sie sich gut zu hohen Dichten (bis 500g Feuchtgewicht/L) im Fermenter anziehen 3) 
wird das geklonte Konstrukt mit dem Rezeptorgen beständig in das Hefegenom 
integriert. Zusätzlich ist die Selektion von Klonen mit mehrfachen Geninsertionen 
möglich 4) ist P. pastoris zum Durchführen der post-translationalen Modifikationen 
fähig (Glykosylierung, Phosphorylierung, Palmitoylierung und Disulfidbindungs-
anordnungen). 5) gibt es keine Hyperglykosylierung des produzierten Proteins, wie in 
dem Fall von S. cerevisiae. 
Insektenzellen und Säugerzellen bieten die authentische Umgebung für die 
Expression von G-Protein gekoppelten Rezeptoren. Diese Expressionssysteme 
haben den eindeutigen Vorteil, dass die Faltung und alle post-translationalen 
Modifikationen am produzierten Rezeptor leistungsfähig durchgeführt werden. Eine 
effektive Methode zur transienten Expression von fremden Proteinen in Insekten- und 
Säugtierzellen bietet sich durch rekombinanten Viren. Eine hohe Infektionsfähigkeit 
in einer Vielfalt von Zellen, die infiziert werden können, ist der Hauptvorteil dieses 
Systems. Im Fall von Insektenzellen werden rekombinante Baculoviren (insekten-
pathogene doppelsträngige-DNS Viren) genutzt. Rekombinante Alfaviren (kleine 
umhüllten Viren mit einem einzelsträngigen RNS-Genom) wie z.B. Semliki-Forest-
Virus, werden zur transienten Expression des fremden Proteins in Säugerzellen 
verwendet. Liljestrom & Garoff entwickelten die SFV-Expressionvektoren mit dem 
Ziel der Produktion großer Mengen von rekombinantem Protein in Säugerzellen   
(Liljestrom&Garoff, 1991). Das SFV-Expressionssystem hat sich als besonders 
geeignet für die GPCR-Expression erwiesen (Lundstrom, 2000). 
 
Der Endothelin B Rezeptor wurde während dieser Arbeit in unterschiedlichen Wirten 
produziert: in der Hefe P. pastoris, in Sf9-Insektenzellen und in CHO-Säugerzellen. 
Die höchste Ausbeute an aktivem Rezeptor wurde in Hefe erhalten; der Klon 
FlagHisETBBio mit einer Expressionsrate von 60 pmol/mg, erbrachte 1,2 mg 
Rezeptor/L Schüttelkultur. Durch Fermentation des gleichen P. pastoris Klons im 
10L-Fermenter, war es möglich, 3kg Hefezellen zu erhalten, die 20-39 mg des 
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Insektenzellen mit einer maximalen Expression von 30 pmol/mg produziert wurde, 
war 0,7 mg Rezeptor/L Zellkultur. Die damit erreichte Menge stimmt mit den vorher 
berichteten Werten überein (Doi et al., 1997). Verglichen mit der ETB Rezeptor-
produktion in Hefe, ist die Ausbeute an aktivem Rezeptor in Insektzellen niedriger 
und die Systembehandlung ist zeitaufwändiger, wird aber durch eine homogene 
Rezeptorpräparation nach der Reinigung belohnt. Die Expression des aktiven ETB-
Rezeptors von 7 pmol/mg in den CHO-Zellen ist niedriger als erwartet, wenn man in 
Betracht zieht, dass das Vektorkonstrukt pSFV3CAPETBHis, der zur 
Rezeptorproduktion benutzt wurde, ein Gen für das Capsidprotein enthält. Dieses 
Gen hat ein „translation-enhancer“ Signal auf seinem 5’-Ende, das im Fall anderer 
GPCRs zu in einer mehrfach höheren Expression im Vergleich zum Konstrukt ohne 
das Capsidprotein führte (Lundstrom et al., 2001). CHO-Zellen sind zweifellos der 
finanziell anspruchsvollste Wirt für die Rezeptorproduktion und kann mit einer in 
dieser Arbeit erzielter Expression von ETB-Rezeptor von 7 pmol/mg nicht für eine 
Rezeptorproduktion in großen Maßstab empfohlen werden. Es sollte erwähnt 
werden, dass der am häufigsten genutzte Wirt zur Proteinproduktion, E. coli, als Wirt 
für die ETB-Produktion in dieser Arbeit nicht ausgewertet wurde. Frühere Versuche in 
E.coli erbrachten 41 aktiv bindende ETB Rezeptor/Zell (Haendler et al., 1993), die 
erreichten Expressionsraten sind aber zu niedrig, um E. coli als konkurrenzfähiges 
System  für die heterologe Produktion des ETB-Rezeptors im großen Maßstab 
betrachten zu können. 
 
Für die Überproduktion des ETB-Rezeptors in Hefe und Insektenzellen wurde der 
Klon FlagHisETBBio ausgesucht, der drei verschiedene Affinitätsanhängseln hat. 
Aufgrund dieser Affinitätsanhängsel war es möglich, einige Reinigungsstrategien zu 
testen und effizientestere zu bestimmen. Außerdem haben diese „Tags“ den 
immunologischen Nachweis von produzierten Rezeptorfusionen ermöglicht. 
Der „Bio-Tag“ wird in P. pastoris und in den Insektzellen biotinyliert, was durch 
Immunoblotanalyse mit Streptavidin bestätigt wurde. Die Präsenz von „Bio-Tag“ 
wurde in dieser Arbeit zur Reinigung der Rezeptorfusion mit Avidin verwendet.  
Auch wurde in dieser Arbeit der Rezeptor immer als Komplex mit dem Liganden ET-1 
gereinigt, der an den Rezeptor fast irreversibel bindet und dadurch den nativen 
Rezeptor stabilisiert. Jedoch war der Nachteil dieser Reinigungsstrategie, dass die 
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unterschiedlichen Reinigungsschritte nicht möglich war. 
 
Der in Hefe überproduzierte Rezeptor wurde mit dem Detergenz n-Dodecyl-ß-D-
Maltozid aus Hefemembranen solubilisiert, da in früheren Solubilisierungsstudien an 
aus Hefe gewonnenem ETB-Rezeptoren dieses Detergenz die besten Ergebnisse 
erzielte (Schiller et al., 2001). 
Als effizienteste Rezeptorreinigung hat sich die zweistufige Affinitätschromatographie 
mittels Ni-NTA und Avidin-Matrix gezeigt. Der Rezeptor wurde zuerst durch die Ni-
NTA-Matrix mittels seines His-Tags gereinigt. Nach diesem Reinigungsschritt waren 
immer noch Verunreinigungen auf dem Silber-gefärbten Gel des Eluats zu sehen. 
Die Avidin-Affinitätsmatrix wurde als zweiter Schritt in der Rezeptorreinigung 
eingesetzt. Dieser Reinigungsschritt erbrachte mehr als 95% reinen Rezeptor (durch 
Silberfärbung abgeschätzt) und meistens enthielt das Eluat nur eine 
Verunreinigungsproteinbande.  
Die Versuche, den Rezeptor über andere Affinitätsmatrizen, wie M1-anti-Flag 
Antikörper und Streptavidin, zu reinigen, wurden wegen starker Aggregationsbildung 
aufgegeben.  
 
Die Aggregationstendenz des in Hefe produzierten ETB-Rezeptors stellte ein ernstes 
Hindernis für die Kristallisationsanforderungen dar. Zahlreiche Versuche wurden in 
dieser Arbeit unternommen, um eine Lösung für dieses Problem zu finden. Es gibt 
eine Vielzahl von möglichen Ursachen für die Rezeptoraggregation. In dieser Arbeit 
wurde eine Anzahl von Additiven zur Vermeidung dieses Verhaltens ausprobiert. 
Darunter waren kurzkettige Lipide (1,2-Dicaproyl-n-Glycero-3-Phosphocholine, 
0,2%), physikalische Chaperone wie Ectoine und Hydroxyectoine (je 1%), 
Cholesterin-hemisuccinate (0,5%) und DMSO (2%). Keins dieser Additive konnte die 
monomere Form des Rezeptors stabilisieren und Bildung von Rezeptoraggregaten 
völlig verhindern. 
Nach der Rezeptorproduktion in Baculovirus infizierten Insektenzellen wurde ein 
geeignetes Detergenz für die Solubilisierung ausgesucht. Die Rezeptoraffinitäts-
messungen mittels radioaktivem [I
125]
 ET-1-Liganden zeigten, dass n-Dodecyl-ß-D-
Maltosid (LM), Lauryl-Saccharose (LS) und Digitonin/Cholat (D/C) die größte Menge 
aktiven Rezeptor brachten. LM wurde für die weitere Arbeit verwendet. Das Konstrukt 
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Schritten mittels über Ni-NTA- und Avidin-Chromatographie analog zur Hefe-
Prozedur  gereinigt. In diesem Fall gelang es eine homogene Form des ETB-
Rezeptors zu erhalten, wie die Gelfiltrationsanalyse  (Superose 6) zeigte. 
 
Angeregt durch kürzlich erschienene Daten bezüglich der Homo- und Hetero-
oligomerisierung von GPCRs, wurde der Oligomerisationszustand des ETB-
Rezeptors durch „native blue“ Elektrophorese untersucht. Eine deutliche Bande mit 
einem Molekulargewicht des Rezeptordimers konnte nachgewiesen werden. Jedoch 
sind weitere Experimente erforderlich, um zu einen definitiven Beweis für die 
Rezeptordimerisierung zu gelangen, da die native Elektrophorese Artefakten in 
manchen Fällen produzieren kann. 
 
Die Hefe P. pastoris konnte als zuverlässiges Produktionssystem für den ETB-
Rezeptor mit hohen Ausbeuten an aktivem Protein etabliert werden. 
Milligrammmengen des gereinigten Rezeptors wurden nach der Affinitätsreinigung 
erhalten, die die Ni-NTA und Avidin-Matrizen kombinierte. Jedoch konnte das 
Problem der Rezeptoraggregation in diesem Fall nur teilweise gelöst werden. 
Weitere Bemühungen sind erforderlich. Die Rezeptorproduktion in den Insektzellen 
ergab weniger Rezeptor im Vergleich zu P. pastoris, ist jedoch vielversprechender, 
da in diesem Fall der Rezeptor in der homogenen monomeren Form nach der 
Reinigung erhalten wurde. Die in Hefe und Insektenzellen produzierten Mengen des 
Rezeptors und seine Aktivität stellen eine gute Grundlage für den Beginn der 3D- 
und zur Fortsetzung von 2D-Kristallisationsversuchen dar. 
 
Obwohl die Expression des ETB-Rezeptors in Säugerzellen mittels Semliki-Forest-
Virus optimiert werden muss, bietet diese Art transienter Expression interessante 
Möglichkeiten für Funktionsstudien, da sich der Rezeptor hier in seiner natürlichen 
Umgebung befindet. Es wäre interessant, die Frage der Rezeptor-Oligomerisierung 
mittels FRET (Fluoreszenzresonanz-Energieübertragung) oder BRET (Bio-
lumineszenzresonanz-Energieübertragung) zu untersuchen. Diese Methoden waren 
sehr informativ im Fall von anderen G-Protein gekoppelten Rezeptoren (Bouvier, 
2002) und konnten interessante Einblicke über die endogene, aktive Form und die in 
vivo Dimerisierung des ETB-Rezeptors geben. Bisher gibt es kein Testsystem für in 
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produziert wurden. Diese Hefe hat sehr niedrige Menge an endogen exprimierten G-
Proteinen und eine sehr begrenzte Zahl unterschiedlicher G-Proteine. Eine 
Möglichkeit wäre einen P. pastoris Stamm genetisch so zu verändern, dass er 
entweder das Protein G16 oder Gq und Gi, die Hauptpartner für die Kopplung mit dem 
ETB, zusammen mit den Untereinheiten βγ produziert. Bei einem solchen Stamm 
wäre es möglich, die Rezeptorsaktivität im Hefesphäroplasten nach Ligandenzugabe 
direkt durch die Ca
2+-Konzentrationsänderungen zu messen.  
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